|
OMIM |
Link |
Information gain |
01 |
|
RA
|
[NCBI]
|
0.00408685
|
|
|
SLE
|
[NCBI]
|
0.00256252
|
|
|
leber optic atrophy, susceptibility to
|
[NCBI]
|
0.00236212
|
|
|
CBBM
|
[NCBI]
|
0.00162603
|
|
|
leber optic atrophy
|
[NCBI]
|
0.00106673
|
|
|
CDB2
|
[NCBI]
|
0.00106379
|
|
|
PARK3
|
[NCBI]
|
0.00101961
|
|
|
xanthomatosis, susceptibility to
|
[NCBI]
|
0.000981931
|
|
|
OFC1
|
[NCBI]
|
0.000806934
|
|
|
MTTL1
|
[NCBI]
|
0.000750068
|
|
|
persistent hyperplastic primary vitreous, autosomal dominant
|
[NCBI]
|
0.000717834
|
|
|
SGM1
|
[NCBI]
|
0.000717834
|
|
|
NNCI
|
[NCBI]
|
0.000717834
|
|
|
cerebrohepatorenal syndrome, variant types
|
[NCBI]
|
0.000717834
|
|
|
TNF
|
[NCBI]
|
0.000681335
|
|
|
FGFR3
|
[NCBI]
|
0.00066575
|
|
|
VEGF
|
[NCBI]
|
0.000637041
|
|
|
persistent hyperplastic primary vitreous, autosomal recessive
|
[NCBI]
|
0.000618849
|
|
|
LI5
|
[NCBI]
|
0.000618849
|
|
|
DYT15
|
[NCBI]
|
0.000618849
|
|
|
DIP
|
[NCBI]
|
0.000618849
|
|
|
FFI
|
[NCBI]
|
0.000564967
|
|
|
sprengel deformity
|
[NCBI]
|
0.000554961
|
|
|
thyroid carcinoma, hurthle cell
|
[NCBI]
|
0.000554961
|
|
|
ARVD3
|
[NCBI]
|
0.000554961
|
|
|
ARVD4
|
[NCBI]
|
0.000554961
|
|
|
ETM2
|
[NCBI]
|
0.000507742
|
|
|
AUTS5
|
[NCBI]
|
0.000507742
|
|
|
HBD
|
[NCBI]
|
0.000507742
|
|
|
hereditary motor and sensory neuropathy v
|
[NCBI]
|
0.000470341
|
|
|
diabetes mellitus, noninsulin-dependent, 3
|
[NCBI]
|
0.000470341
|
|
|
ATOD6
|
[NCBI]
|
0.000470341
|
|
|
bullous erythroderma ichthyosiformis congenita of brocq
|
[NCBI]
|
0.000460923
|
|
|
MDD
|
[NCBI]
|
0.000457407
|
|
|
diabetes-deafness syndrome, maternally transmitted
|
[NCBI]
|
0.000442817
|
|
|
neuropathy, hereditary motor and sensory, russe type
|
[NCBI]
|
0.000439426
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
0.0004296
|
|
|
AUTS9
|
[NCBI]
|
0.000413123
|
|
|
SRS
|
[NCBI]
|
0.000404788
|
|
|
EGF
|
[NCBI]
|
0.000391656
|
|
|
NGFB
|
[NCBI]
|
0.000391285
|
|
|
digeorge syndrome/velocardiofacial syndrome spectrum of malformation 2
|
[NCBI]
|
0.000390267
|
|
|
PRL
|
[NCBI]
|
0.000386815
|
|
|
HYPX
|
[NCBI]
|
0.000370087
|
|
|
NPY
|
[NCBI]
|
0.000369487
|
|
|
giant platelet syndrome
|
[NCBI]
|
0.000368236
|
|
|
MTATP6
|
[NCBI]
|
0.000355253
|
|
|
pygmy
|
[NCBI]
|
0.000352044
|
|
|
HBA2
|
[NCBI]
|
0.00034
|
|
|
CF
|
[NCBI]
|
0.000339199
|
|
|
MTHFR
|
[NCBI]
|
0.000336152
|
|
|
HBB
|
[NCBI]
|
0.000324364
|
|
|
KLK3
|
[NCBI]
|
0.000311854
|
|
|
PMD
|
[NCBI]
|
0.000309532
|
|
|
PMP22
|
[NCBI]
|
0.00030147
|
|
|
neuropathy, congenital hypomyelinating
|
[NCBI]
|
0.000298563
|
|
|
LS
|
[NCBI]
|
0.000298433
|
|
|
DURS1
|
[NCBI]
|
0.000294745
|
|
|
MG
|
[NCBI]
|
0.000282745
|
|
|
AIS
|
[NCBI]
|
0.000276267
|
|
|
CRH
|
[NCBI]
|
0.000275896
|
|
|
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity
|
[NCBI]
|
0.000271637
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.000269295
|
|
|
PTH
|
[NCBI]
|
0.000268241
|
|
|
FGFR2
|
[NCBI]
|
0.000264753
|
|
|
VIP
|
[NCBI]
|
0.000249436
|
|
|
LI1
|
[NCBI]
|
0.000248822
|
|
|
AD
|
[NCBI]
|
0.000247494
|
|
|
MELAS
|
[NCBI]
|
0.000236166
|
|
|
TTR
|
[NCBI]
|
0.000235527
|
|
|
alport syndrome, autosomal dominant
|
[NCBI]
|
0.000235212
|
|
|
scleroderma, familial progressive
|
[NCBI]
|
0.000235212
|
|
|
factor v deficiency
|
[NCBI]
|
0.000228127
|
|
|
MPZ
|
[NCBI]
|
0.000226844
|
|
|
RET
|
[NCBI]
|
0.000225101
|
|
|
CCK
|
[NCBI]
|
0.000224226
|
|
|
ACH
|
[NCBI]
|
0.000218377
|
|
|
CDA
|
[NCBI]
|
0.000214668
|
|
|
pfeiffer syndrome
|
[NCBI]
|
0.000205046
|
|
|
glycogen storage disease vii
|
[NCBI]
|
0.000195355
|
|
|
CD
|
[NCBI]
|
0.000194753
|
|
|
AVP
|
[NCBI]
|
0.000193531
|
|
|
CJD
|
[NCBI]
|
0.000192953
|
|
|
MBP
|
[NCBI]
|
0.000191199
|
|
|
EBS-MP
|
[NCBI]
|
0.000190478
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
0.000185922
|
|
|
HGF
|
[NCBI]
|
0.00018537
|
|
|
CEACAM5
|
[NCBI]
|
0.000185299
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
0.000183654
|
|
|
BDNF
|
[NCBI]
|
0.00018341
|
|
|
ACHE
|
[NCBI]
|
0.000182392
|
|
|
COL2A1
|
[NCBI]
|
0.000181086
|
|
|
segawa syndrome, autosomal recessive
|
[NCBI]
|
0.000180135
|
|
|
HYPP
|
[NCBI]
|
0.000175713
|
|
|
SCCMS
|
[NCBI]
|
0.000174035
|
|
|
NF2
|
[NCBI]
|
0.000173763
|
|
|
CDB1
|
[NCBI]
|
0.000167701
|
|
|
muenke syndrome
|
[NCBI]
|
0.000167701
|
|
|
TH
|
[NCBI]
|
0.000166186
|
|
|
AFP
|
[NCBI]
|
0.000165459
|
|
|
DMD
|
[NCBI]
|
0.000163912
|
|
|
TGFBI
|
[NCBI]
|
0.000162566
|
|
|
TSD
|
[NCBI]
|
0.000160658
|
|
|
CRC
|
[NCBI]
|
0.000158563
|
|
|
DHFR
|
[NCBI]
|
0.000150794
|
|
|
myelofibrosis, familial
|
[NCBI]
|
0.000149801
|
|
|
ichthyosis, cyclic, with epidermolytic hyperkeratosis
|
[NCBI]
|
0.000149801
|
|
|
striatonigral degeneration, infantile, mitochondrial
|
[NCBI]
|
0.000149801
|
|
|
GFAP
|
[NCBI]
|
0.000148968
|
|
|
MYOC
|
[NCBI]
|
0.000148821
|
|
|
MTTS1
|
[NCBI]
|
0.000146168
|
|
|
HCH
|
[NCBI]
|
0.000145581
|
|
|
COL7A1
|
[NCBI]
|
0.000144445
|
|
|
amyloidosis vii
|
[NCBI]
|
0.000142842
|
|
|
peters anomaly
|
[NCBI]
|
0.000142842
|
|
|
charcot-marie-tooth disease, axonal, type 2j
|
[NCBI]
|
0.000142842
|
|
|
PCOS1
|
[NCBI]
|
0.000142815
|
|
|
factor vii deficiency
|
[NCBI]
|
0.000141159
|
|
|
KRT5
|
[NCBI]
|
0.000138222
|
|
|
GJB2
|
[NCBI]
|
0.000137941
|
|
|
PCNA
|
[NCBI]
|
0.000136186
|
|
|
VRNI
|
[NCBI]
|
0.000135856
|
|
|
CFTR
|
[NCBI]
|
0.000135426
|
|
|
SOD1
|
[NCBI]
|
0.000135395
|
|
|
PEE1
|
[NCBI]
|
0.000134859
|
|
|
G6PD
|
[NCBI]
|
0.000131199
|
|
|
PSACH
|
[NCBI]
|
0.000130878
|
|
|
HHF1
|
[NCBI]
|
0.000129963
|
|
|
MODY
|
[NCBI]
|
0.000129541
|
|
|
CHAT
|
[NCBI]
|
0.000128042
|
|
|
VHL
|
[NCBI]
|
0.000127584
|
|
|
GSD
|
[NCBI]
|
0.000125167
|
|
|
RYR1
|
[NCBI]
|
0.000122293
|
|
|
PARK7
|
[NCBI]
|
0.000121094
|
|
|
hyperferritinemia-cataract syndrome
|
[NCBI]
|
0.000121094
|
|
|
alkaptonuria
|
[NCBI]
|
0.000120084
|
|
|
alzheimer disease 3
|
[NCBI]
|
0.000119056
|
|
|
LHCGR
|
[NCBI]
|
0.000118635
|
|
|
TD1
|
[NCBI]
|
0.000113041
|
|
|
porphyria variegata
|
[NCBI]
|
0.000113041
|
|
|
macular dystrophy, vitelliform, adult-onset
|
[NCBI]
|
0.000112838
|
|
|
charcot-marie-tooth disease, axonal, type 2i
|
[NCBI]
|
0.000112026
|
|
|
dystonia, familial, with visual failure and striatal lucencies
|
[NCBI]
|
0.000112026
|
|
|
ovarian hyperstimulation syndrome
|
[NCBI]
|
0.000112026
|
|
|
FENIB
|
[NCBI]
|
0.000112026
|
|
|
LWD
|
[NCBI]
|
0.000111931
|
|
|
HBG2
|
[NCBI]
|
0.00011054
|
|
|
RHO
|
[NCBI]
|
0.000109932
|
|
|
trifunctional protein deficiency
|
[NCBI]
|
0.000105707
|
|
|
CDG2A
|
[NCBI]
|
0.000105707
|
|
|
alzheimer disease, susceptibility to, mitochondrial
|
[NCBI]
|
0.000105707
|
|
|
SMMCI
|
[NCBI]
|
0.000105707
|
|
|
CMT1A
|
[NCBI]
|
0.000105679
|
|
|
PSEN1
|
[NCBI]
|
0.000105253
|
|
|
NPPA
|
[NCBI]
|
0.000104665
|
|
|
HHF2
|
[NCBI]
|
0.000103148
|
|
|
KIT
|
[NCBI]
|
0.00010169
|
|
|
MYH7
|
[NCBI]
|
0.00010169
|
|
|
SCN4A
|
[NCBI]
|
0.000101112
|
|
|
LDLR
|
[NCBI]
|
0.000100633
|
|
|
ALD
|
[NCBI]
|
0.000100293
|
|
|
CDL1
|
[NCBI]
|
9.94402e-05
|
|
|
myeloperoxidase deficiency
|
[NCBI]
|
9.94402e-05
|
|
|
MTTI
|
[NCBI]
|
9.89263e-05
|
|
|
CMTX1
|
[NCBI]
|
9.88893e-05
|
|
|
EPO
|
[NCBI]
|
9.76065e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, infantile
|
[NCBI]
|
9.52172e-05
|
|
|
NDP
|
[NCBI]
|
9.46018e-05
|
|
|
GLRA1
|
[NCBI]
|
9.42975e-05
|
|
|
SFD
|
[NCBI]
|
9.38607e-05
|
|
|
LGMD2D
|
[NCBI]
|
9.38607e-05
|
|
|
MERRF
|
[NCBI]
|
9.38607e-05
|
|
|
congenital cataracts, facial dysmorphism, and neuropathy
|
[NCBI]
|
9.38607e-05
|
|
|
FBN1
|
[NCBI]
|
9.23215e-05
|
|
|
BTHS
|
[NCBI]
|
9.17275e-05
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
9.10779e-05
|
|
|
KSS
|
[NCBI]
|
9.06753e-05
|
|
|
ODDD
|
[NCBI]
|
8.95451e-05
|
|
|
hyperekplexia, hereditary
|
[NCBI]
|
8.95451e-05
|
|
|
central core disease of muscle
|
[NCBI]
|
8.95451e-05
|
|
|
thiopurine s-methyltransferase deficiency
|
[NCBI]
|
8.88404e-05
|
|
|
WAS
|
[NCBI]
|
8.68906e-05
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
8.68721e-05
|
|
|
diabetes insipidus, nephrogenic, x-linked
|
[NCBI]
|
8.66079e-05
|
|
|
TP53
|
[NCBI]
|
8.57576e-05
|
|
|
FTL
|
[NCBI]
|
8.52695e-05
|
|
|
VHL
|
[NCBI]
|
8.51996e-05
|
|
|
F2
|
[NCBI]
|
8.46948e-05
|
|
|
LPG
|
[NCBI]
|
8.42843e-05
|
|
|
GCCD1
|
[NCBI]
|
8.42843e-05
|
|
|
langer mesomelic dysplasia
|
[NCBI]
|
8.42843e-05
|
|
|
NEM1
|
[NCBI]
|
8.38294e-05
|
|
|
keratosis palmoplantaris striata i
|
[NCBI]
|
8.38294e-05
|
|
|
metaphyseal chondrodysplasia, jansen type
|
[NCBI]
|
8.38294e-05
|
|
|
muscle glycogenosis, x-linked
|
[NCBI]
|
8.38294e-05
|
|
|
shprintzen-goldberg craniosynostosis syndrome
|
[NCBI]
|
8.38294e-05
|
|
|
epidermolysis bullosa herpetiformis, dowling-meara type
|
[NCBI]
|
8.38294e-05
|
|
|
BTK
|
[NCBI]
|
8.3678e-05
|
|
|
RP
|
[NCBI]
|
8.36715e-05
|
|
|
JPS
|
[NCBI]
|
8.32217e-05
|
|
|
AR
|
[NCBI]
|
8.30002e-05
|
|
|
MFS
|
[NCBI]
|
8.23019e-05
|
|
|
PARK2
|
[NCBI]
|
8.15077e-05
|
|
|
MTTK
|
[NCBI]
|
8.08802e-05
|
|
|
L1CAM
|
[NCBI]
|
8.05126e-05
|
|
|
aging
|
[NCBI]
|
8.01197e-05
|
|
|
holocarboxylase synthetase deficiency
|
[NCBI]
|
8.01197e-05
|
|
|
HBA1
|
[NCBI]
|
7.94336e-05
|
|
|
ND
|
[NCBI]
|
7.8512e-05
|
|
|
COL3A1
|
[NCBI]
|
7.83664e-05
|
|
|
AVPR2
|
[NCBI]
|
7.81959e-05
|
|
|
HSCR1
|
[NCBI]
|
7.81623e-05
|
|
|
GCE
|
[NCBI]
|
7.62901e-05
|
|
|
FED
|
[NCBI]
|
7.62901e-05
|
|
|
CSID
|
[NCBI]
|
7.62901e-05
|
|
|
ATM
|
[NCBI]
|
7.58608e-05
|
|
|
PWS
|
[NCBI]
|
7.57525e-05
|
|
|
F13A1
|
[NCBI]
|
7.5332e-05
|
|
|
STHAG1
|
[NCBI]
|
7.52152e-05
|
|
|
adenylosuccinase deficiency
|
[NCBI]
|
7.52152e-05
|
|
|
ARVD2
|
[NCBI]
|
7.52152e-05
|
|
|
optic atrophy 1 and deafness
|
[NCBI]
|
7.52152e-05
|
|
|
gaucher disease, atypical, due to saposin c deficiency
|
[NCBI]
|
7.52152e-05
|
|
|
charcot-marie-tooth disease and deafness
|
[NCBI]
|
7.52152e-05
|
|
|
keratoderma, palmoplantar, with deafness
|
[NCBI]
|
7.52152e-05
|
|
|
RP14
|
[NCBI]
|
7.52152e-05
|
|
|
myotonia, potassium-aggravated
|
[NCBI]
|
7.52152e-05
|
|
|
SRY
|
[NCBI]
|
7.50132e-05
|
|
|
ECYT4
|
[NCBI]
|
7.48947e-05
|
|
|
HHF5
|
[NCBI]
|
7.48947e-05
|
|
|
PARK13
|
[NCBI]
|
7.48947e-05
|
|
|
radioulnar synostosis with amegakaryocytic thrombocytopenia
|
[NCBI]
|
7.48947e-05
|
|
|
RP36
|
[NCBI]
|
7.48947e-05
|
|
|
CMD1X
|
[NCBI]
|
7.48947e-05
|
|
|
immunodeficiency due to defect in mapbp-interacting protein
|
[NCBI]
|
7.48947e-05
|
|
|
cone-rod dystrophy 11
|
[NCBI]
|
7.48947e-05
|
|
|
XLN
|
[NCBI]
|
7.48947e-05
|
|
|
hyaluronidase deficiency
|
[NCBI]
|
7.48947e-05
|
|
|
WR
|
[NCBI]
|
7.48947e-05
|
|
|
CDG1L
|
[NCBI]
|
7.48947e-05
|
|
|
CMH2
|
[NCBI]
|
7.48947e-05
|
|
|
hypertension, early-onset, autosomal dominant, with severe exacerbation in pregnancy
|
[NCBI]
|
7.48947e-05
|
|
|
immunodeficiency with hyper-igm, type 5
|
[NCBI]
|
7.48947e-05
|
|
|
ARVD8
|
[NCBI]
|
7.48947e-05
|
|
|
hyperlipoproteinemia, type v
|
[NCBI]
|
7.48947e-05
|
|
|
glutamine deficiency, congenital
|
[NCBI]
|
7.48947e-05
|
|
|
RCD4
|
[NCBI]
|
7.48947e-05
|
|
|
JBTS7
|
[NCBI]
|
7.48947e-05
|
|
|
LGMD2M
|
[NCBI]
|
7.48947e-05
|
|
|
MKS5
|
[NCBI]
|
7.48947e-05
|
|
|
POF2B
|
[NCBI]
|
7.48947e-05
|
|
|
PFKM
|
[NCBI]
|
7.43825e-05
|
|
|
PRNP
|
[NCBI]
|
7.42757e-05
|
|
|
MTTN
|
[NCBI]
|
7.31414e-05
|
|
|
KRT14
|
[NCBI]
|
7.29102e-05
|
|
|
ALS1
|
[NCBI]
|
7.27969e-05
|
|
|
MC1R
|
[NCBI]
|
7.26127e-05
|
|
|
MPO
|
[NCBI]
|
7.2283e-05
|
|
|
GAA
|
[NCBI]
|
7.2178e-05
|
|
|
CDKN2A
|
[NCBI]
|
7.2097e-05
|
|
|
HMBS
|
[NCBI]
|
7.17398e-05
|
|
|
GBA
|
[NCBI]
|
7.14419e-05
|
|
|
TNFSF6
|
[NCBI]
|
7.10622e-05
|
|
|
CCM
|
[NCBI]
|
7.06046e-05
|
|
|
EA2
|
[NCBI]
|
6.94632e-05
|
|
|
SCN1
|
[NCBI]
|
6.94632e-05
|
|
|
mitochondrial complex iv deficiency
|
[NCBI]
|
6.94323e-05
|
|
|
MTRNR1
|
[NCBI]
|
6.87435e-05
|
|
|
TD2
|
[NCBI]
|
6.83085e-05
|
|
|
F5F8D
|
[NCBI]
|
6.83085e-05
|
|
|
NEM2
|
[NCBI]
|
6.83085e-05
|
|
|
wolfram syndrome, mitochondrial form
|
[NCBI]
|
6.83085e-05
|
|
|
FHL2
|
[NCBI]
|
6.83085e-05
|
|
|
succinyl-coa:3-oxoacid coa transferase deficiency
|
[NCBI]
|
6.83085e-05
|
|
|
cardiomyopathy, dilated, with woolly hair and keratoderma
|
[NCBI]
|
6.83085e-05
|
|
|
CCM3
|
[NCBI]
|
6.83085e-05
|
|
|
endometrial cancer
|
[NCBI]
|
6.83085e-05
|
|
|
CD
|
[NCBI]
|
6.82765e-05
|
|
|
MTND6
|
[NCBI]
|
6.74566e-05
|
|
|
HIDS
|
[NCBI]
|
6.63993e-05
|
|
|
GEFS+
|
[NCBI]
|
6.63993e-05
|
|
|
KRT9
|
[NCBI]
|
6.62464e-05
|
|
|
HGD
|
[NCBI]
|
6.62464e-05
|
|
|
CLCN1
|
[NCBI]
|
6.62151e-05
|
|
|
POU1F1
|
[NCBI]
|
6.62151e-05
|
|
|
HFE
|
[NCBI]
|
6.50323e-05
|
|
|
GJB1
|
[NCBI]
|
6.45118e-05
|
|
|
CHM
|
[NCBI]
|
6.44247e-05
|
|
|
WAS
|
[NCBI]
|
6.41331e-05
|
|
|
KRT10
|
[NCBI]
|
6.38369e-05
|
|
|
PARK8
|
[NCBI]
|
6.35335e-05
|
|
|
masa syndrome
|
[NCBI]
|
6.35335e-05
|
|
|
FIH
|
[NCBI]
|
6.34654e-05
|
|
|
PRPH2
|
[NCBI]
|
6.27354e-05
|
|
|
kuru, susceptibility to
|
[NCBI]
|
6.2564e-05
|
|
|
ehlers-danlos syndrome, type iii
|
[NCBI]
|
6.2564e-05
|
|
|
MDC1C
|
[NCBI]
|
6.2564e-05
|
|
|
DFNB3
|
[NCBI]
|
6.2564e-05
|
|
|
TGM1
|
[NCBI]
|
6.20729e-05
|
|
|
SLC6A3
|
[NCBI]
|
6.10226e-05
|
|
|
MNGIE
|
[NCBI]
|
6.08447e-05
|
|
|
KCNA1
|
[NCBI]
|
6.06531e-05
|
|
|
RNASE3
|
[NCBI]
|
6.042e-05
|
|
|
APP
|
[NCBI]
|
6.00384e-05
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
5.98433e-05
|
|
|
CTNS
|
[NCBI]
|
5.98433e-05
|
|
|
MTTE
|
[NCBI]
|
5.9403e-05
|
|
|
OTC
|
[NCBI]
|
5.9049e-05
|
|
|
FSHR
|
[NCBI]
|
5.86211e-05
|
|
|
long-chain 3-hydroxyacyl-coa dehydrogenase deficiency
|
[NCBI]
|
5.83151e-05
|
|
|
PLP1
|
[NCBI]
|
5.82654e-05
|
|
|
SLC4A1
|
[NCBI]
|
5.79736e-05
|
|
|
fructose-1,6-bisphosphatase deficiency
|
[NCBI]
|
5.76633e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 2
|
[NCBI]
|
5.76633e-05
|
|
|
SYM1
|
[NCBI]
|
5.76633e-05
|
|
|
alpha-methylacetoacetic aciduria
|
[NCBI]
|
5.76633e-05
|
|
|
DFNA3
|
[NCBI]
|
5.76633e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, lethal neonatal
|
[NCBI]
|
5.76633e-05
|
|
|
dyskeratosis congenita, autosomal dominant
|
[NCBI]
|
5.76633e-05
|
|
|
MODY2
|
[NCBI]
|
5.76633e-05
|
|
|
HHF6
|
[NCBI]
|
5.76633e-05
|
|
|
crigler-najjar syndrome, type ii
|
[NCBI]
|
5.76633e-05
|
|
|
GCK
|
[NCBI]
|
5.7576e-05
|
|
|
ARSA
|
[NCBI]
|
5.73367e-05
|
|
|
EGFR
|
[NCBI]
|
5.69721e-05
|
|
|
SPTB
|
[NCBI]
|
5.67523e-05
|
|
|
COL1A1
|
[NCBI]
|
5.65528e-05
|
|
|
ABCC8
|
[NCBI]
|
5.65528e-05
|
|
|
MTND4
|
[NCBI]
|
5.45823e-05
|
|
|
F3
|
[NCBI]
|
5.45775e-05
|
|
|
CD40LG
|
[NCBI]
|
5.44072e-05
|
|
|
GH1
|
[NCBI]
|
5.39169e-05
|
|
|
HOKPP
|
[NCBI]
|
5.36748e-05
|
|
|
schwannomatosis
|
[NCBI]
|
5.34039e-05
|
|
|
CLN8
|
[NCBI]
|
5.34039e-05
|
|
|
CMT4C
|
[NCBI]
|
5.34039e-05
|
|
|
RTT
|
[NCBI]
|
5.33383e-05
|
|
|
apc gene
|
[NCBI]
|
5.28953e-05
|
|
|
COMT
|
[NCBI]
|
5.27242e-05
|
|
|
UGT1A1
|
[NCBI]
|
5.25415e-05
|
|
|
GNAS
|
[NCBI]
|
5.19657e-05
|
|
|
MTTW
|
[NCBI]
|
5.19289e-05
|
|
|
von willebrand disease
|
[NCBI]
|
5.16794e-05
|
|
|
MRXHF1
|
[NCBI]
|
5.15394e-05
|
|
|
ehlers-danlos syndrome, type iv, autosomal dominant
|
[NCBI]
|
5.15394e-05
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
4.9993e-05
|
|
|
IRID2
|
[NCBI]
|
4.96485e-05
|
|
|
phosphoglycerate kinase 1 deficiency
|
[NCBI]
|
4.96485e-05
|
|
|
DFNA12
|
[NCBI]
|
4.96485e-05
|
|
|
kniest dysplasia
|
[NCBI]
|
4.96485e-05
|
|
|
SPP1
|
[NCBI]
|
4.95603e-05
|
|
|
HNFJ
|
[NCBI]
|
4.95134e-05
|
|
|
FKTN
|
[NCBI]
|
4.88786e-05
|
|
|
COL1A2
|
[NCBI]
|
4.83714e-05
|
|
|
HEXA
|
[NCBI]
|
4.83714e-05
|
|
|
CASR
|
[NCBI]
|
4.8311e-05
|
|
|
FXN
|
[NCBI]
|
4.78436e-05
|
|
|
FLNA
|
[NCBI]
|
4.78436e-05
|
|
|
MTTP
|
[NCBI]
|
4.78208e-05
|
|
|
TSC2
|
[NCBI]
|
4.76202e-05
|
|
|
schizencephaly
|
[NCBI]
|
4.76032e-05
|
|
|
thanatophoric dysplasia, glasgow variant
|
[NCBI]
|
4.76032e-05
|
|
|
ASD2
|
[NCBI]
|
4.76032e-05
|
|
|
hypophosphatasia, childhood
|
[NCBI]
|
4.76032e-05
|
|
|
BDB2
|
[NCBI]
|
4.76032e-05
|
|
|
erythrocytosis, familial, 3
|
[NCBI]
|
4.76032e-05
|
|
|
malignant hyperthermia, susceptibility to, 5
|
[NCBI]
|
4.76032e-05
|
|
|
cataract, nonnuclear polymorphic congenital, autosomal dominant
|
[NCBI]
|
4.76032e-05
|
|
|
AKV
|
[NCBI]
|
4.76032e-05
|
|
|
CMT1D
|
[NCBI]
|
4.76032e-05
|
|
|
bothnia retinal dystrophy
|
[NCBI]
|
4.76032e-05
|
|
|
epiphyseal dysplasia, multiple, with myopia and conductive deafness
|
[NCBI]
|
4.76032e-05
|
|
|
CDL3A
|
[NCBI]
|
4.76032e-05
|
|
|
AOIII
|
[NCBI]
|
4.76032e-05
|
|
|
myopathy, spheroid body
|
[NCBI]
|
4.76032e-05
|
|
|
cutis gyrata syndrome of beare and stevenson
|
[NCBI]
|
4.76032e-05
|
|
|
GLC1G
|
[NCBI]
|
4.76032e-05
|
|
|
CMH8
|
[NCBI]
|
4.76032e-05
|
|
|
CMH10
|
[NCBI]
|
4.76032e-05
|
|
|
NEPPK
|
[NCBI]
|
4.76032e-05
|
|
|
muscular dystrophy, scapulohumeral
|
[NCBI]
|
4.76032e-05
|
|
|
heterotopia, periventricular, ehlers-danlos variant
|
[NCBI]
|
4.76032e-05
|
|
|
HMN7B
|
[NCBI]
|
4.76032e-05
|
|
|
AME2
|
[NCBI]
|
4.76032e-05
|
|
|
THRB
|
[NCBI]
|
4.70521e-05
|
|
|
ITGA2
|
[NCBI]
|
4.68944e-05
|
|
|
LRRK2
|
[NCBI]
|
4.64935e-05
|
|
|
homocystinuria
|
[NCBI]
|
4.64334e-05
|
|
|
THC1
|
[NCBI]
|
4.63e-05
|
|
|
mitochondrial dna depletion syndrome, myopathic form
|
[NCBI]
|
4.63e-05
|
|
|
MTC
|
[NCBI]
|
4.63e-05
|
|
|
plasminogen deficiency, type i
|
[NCBI]
|
4.63e-05
|
|
|
CMT1B
|
[NCBI]
|
4.62821e-05
|
|
|
NPS
|
[NCBI]
|
4.62821e-05
|
|
|
FGA
|
[NCBI]
|
4.59441e-05
|
|
|
PKLR
|
[NCBI]
|
4.57021e-05
|
|
|
NR0B1
|
[NCBI]
|
4.57021e-05
|
|
|
GDNF
|
[NCBI]
|
4.53384e-05
|
|
|
3-@hydroxy-3-methylglutaryl-coa lyase deficiency
|
[NCBI]
|
4.50808e-05
|
|
|
GALC
|
[NCBI]
|
4.49635e-05
|
|
|
ATP7B
|
[NCBI]
|
4.48808e-05
|
|
|
phenylketonuria
|
[NCBI]
|
4.42662e-05
|
|
|
PDHA1
|
[NCBI]
|
4.40831e-05
|
|
|
STGD1
|
[NCBI]
|
4.40087e-05
|
|
|
MAPT
|
[NCBI]
|
4.34606e-05
|
|
|
GGCX
|
[NCBI]
|
4.3412e-05
|
|
|
CTNS
|
[NCBI]
|
4.3412e-05
|
|
|
AGL
|
[NCBI]
|
4.3412e-05
|
|
|
COCH
|
[NCBI]
|
4.3412e-05
|
|
|
IDUA
|
[NCBI]
|
4.33267e-05
|
|
|
CDGG1
|
[NCBI]
|
4.32868e-05
|
|
|
amyloidosis v
|
[NCBI]
|
4.32868e-05
|
|
|
phosphoribosylpyrophosphate synthetase superactivity
|
[NCBI]
|
4.32868e-05
|
|
|
denys-drash syndrome
|
[NCBI]
|
4.32868e-05
|
|
|
NCIE1
|
[NCBI]
|
4.32868e-05
|
|
|
parkinson disease, mitochondrial
|
[NCBI]
|
4.32868e-05
|
|
|
KRAS
|
[NCBI]
|
4.26842e-05
|
|
|
GAPDH
|
[NCBI]
|
4.26411e-05
|
|
|
FCMD
|
[NCBI]
|
4.25524e-05
|
|
|
HHC1
|
[NCBI]
|
4.23419e-05
|
|
|
SGCA
|
[NCBI]
|
4.18674e-05
|
|
|
THBD
|
[NCBI]
|
4.18674e-05
|
|
|
PITX2
|
[NCBI]
|
4.184e-05
|
|
|
C1NH
|
[NCBI]
|
4.184e-05
|
|
|
COL17A1
|
[NCBI]
|
4.184e-05
|
|
|
CPI
|
[NCBI]
|
4.18346e-05
|
|
|
MUC1
|
[NCBI]
|
4.16768e-05
|
|
|
AHR
|
[NCBI]
|
4.06176e-05
|
|
|
EA1
|
[NCBI]
|
4.05548e-05
|
|
|
methionine adenosyltransferase deficiency
|
[NCBI]
|
4.05548e-05
|
|
|
complement component 7 deficiency
|
[NCBI]
|
4.05548e-05
|
|
|
LGMD2I
|
[NCBI]
|
4.05548e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive
|
[NCBI]
|
4.05548e-05
|
|
|
mitochondrial dna depletion syndrome, hepatocerebral form
|
[NCBI]
|
4.05548e-05
|
|
|
diabetes insipidus, nephrogenic, autosomal
|
[NCBI]
|
4.05548e-05
|
|
|
OPD2
|
[NCBI]
|
4.05548e-05
|
|
|
COL4A5
|
[NCBI]
|
3.99619e-05
|
|
|
DPYD
|
[NCBI]
|
3.99619e-05
|
|
|
GCDH
|
[NCBI]
|
3.99619e-05
|
|
|
CTSC
|
[NCBI]
|
3.97326e-05
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
3.92259e-05
|
|
|
DJS
|
[NCBI]
|
3.92259e-05
|
|
|
MTM1
|
[NCBI]
|
3.91369e-05
|
|
|
FMF
|
[NCBI]
|
3.91065e-05
|
|
|
ERCC2
|
[NCBI]
|
3.90757e-05
|
|
|
CAPN3
|
[NCBI]
|
3.90757e-05
|
|
|
JAK2
|
[NCBI]
|
3.84215e-05
|
|
|
ARSE
|
[NCBI]
|
3.82984e-05
|
|
|
TK2
|
[NCBI]
|
3.82984e-05
|
|
|
PTK2
|
[NCBI]
|
3.82868e-05
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
3.82281e-05
|
|
|
MTND5
|
[NCBI]
|
3.82218e-05
|
|
|
lipoid congenital adrenal hyperplasia
|
[NCBI]
|
3.80621e-05
|
|
|
GAN1
|
[NCBI]
|
3.80621e-05
|
|
|
myotonia congenita, autosomal dominant
|
[NCBI]
|
3.80621e-05
|
|
|
waardenburg-shah syndrome
|
[NCBI]
|
3.80621e-05
|
|
|
JH
|
[NCBI]
|
3.80621e-05
|
|
|
complement factor h deficiency
|
[NCBI]
|
3.80621e-05
|
|
|
heterotopia, periventricular, x-linked dominant
|
[NCBI]
|
3.80621e-05
|
|
|
ADRB3
|
[NCBI]
|
3.78303e-05
|
|
|
CACNA1A
|
[NCBI]
|
3.77977e-05
|
|
|
ABCD1
|
[NCBI]
|
3.77822e-05
|
|
|
LGMD2A
|
[NCBI]
|
3.77674e-05
|
|
|
SPG3A
|
[NCBI]
|
3.77674e-05
|
|
|
male infertility with large-headed, multiflagellar, polyploid spermatozoa
|
[NCBI]
|
3.76024e-05
|
|
|
DFNB21
|
[NCBI]
|
3.76024e-05
|
|
|
fundus dystrophy, pseudoinflammatory, recessive form
|
[NCBI]
|
3.76024e-05
|
|
|
CSNBAD2
|
[NCBI]
|
3.76024e-05
|
|
|
bile acid synthesis defect, congenital, 2
|
[NCBI]
|
3.76024e-05
|
|
|
insulin-like growth factor i, resistance to
|
[NCBI]
|
3.76024e-05
|
|
|
hyperphenylalaninemia with primapterinuria
|
[NCBI]
|
3.76024e-05
|
|
|
toenail dystrophy, isolated
|
[NCBI]
|
3.76024e-05
|
|
|
hypothyroidism, athyroidal, with spiky hair and cleft palate
|
[NCBI]
|
3.76024e-05
|
|
|
MRX63
|
[NCBI]
|
3.76024e-05
|
|
|
PEOA4
|
[NCBI]
|
3.76024e-05
|
|
|
epidermolysis bullosa, pretibial
|
[NCBI]
|
3.76024e-05
|
|
|
ehlers-danlos-like syndrome due to tenascin-x deficiency
|
[NCBI]
|
3.76024e-05
|
|
|
glycogen storage disease 0, liver
|
[NCBI]
|
3.76024e-05
|
|
|
meniere disease
|
[NCBI]
|
3.76024e-05
|
|
|
fibular hypoplasia and complex brachydactyly
|
[NCBI]
|
3.76024e-05
|
|
|
mullerian aplasia
|
[NCBI]
|
3.76024e-05
|
|
|
adenosine triphosphate, elevated, of erythrocytes
|
[NCBI]
|
3.76024e-05
|
|
|
macular dystrophy, concentric annular
|
[NCBI]
|
3.76024e-05
|
|
|
nevus, epidermal, epidermolytic hyperkeratotic type
|
[NCBI]
|
3.76024e-05
|
|
|
LVNCX
|
[NCBI]
|
3.76024e-05
|
|
|
mass syndrome
|
[NCBI]
|
3.76024e-05
|
|
|
otofaciocervical syndrome
|
[NCBI]
|
3.76024e-05
|
|
|
brunner syndrome
|
[NCBI]
|
3.76024e-05
|
|
|
micromelic bone dysplasia with cloverleaf skull
|
[NCBI]
|
3.76024e-05
|
|
|
bile acid synthesis defect, congenital, 4
|
[NCBI]
|
3.76024e-05
|
|
|
COD3
|
[NCBI]
|
3.76024e-05
|
|
|
CMD3A
|
[NCBI]
|
3.76024e-05
|
|
|
brugada syndrome 2
|
[NCBI]
|
3.76024e-05
|
|
|
mandibulofacial dysostosis, treacher collins type, autosomal recessive
|
[NCBI]
|
3.76024e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2e
|
[NCBI]
|
3.76024e-05
|
|
|
MAFD6
|
[NCBI]
|
3.75367e-05
|
|
|
TG
|
[NCBI]
|
3.7095e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
3.68053e-05
|
|
|
PPOX
|
[NCBI]
|
3.66026e-05
|
|
|
GSN
|
[NCBI]
|
3.66026e-05
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
3.66026e-05
|
|
|
MTTQ
|
[NCBI]
|
3.65681e-05
|
|
|
MGAT2
|
[NCBI]
|
3.65681e-05
|
|
|
FRDA
|
[NCBI]
|
3.64235e-05
|
|
|
PPARA
|
[NCBI]
|
3.64158e-05
|
|
|
KRTHB6
|
[NCBI]
|
3.61454e-05
|
|
|
pyruvate carboxylase deficiency
|
[NCBI]
|
3.57753e-05
|
|
|
PARK6
|
[NCBI]
|
3.57753e-05
|
|
|
DLB
|
[NCBI]
|
3.57753e-05
|
|
|
alexander disease
|
[NCBI]
|
3.57753e-05
|
|
|
PYGM
|
[NCBI]
|
3.55292e-05
|
|
|
CPT2
|
[NCBI]
|
3.55292e-05
|
|
|
temporal arteritis
|
[NCBI]
|
3.52499e-05
|
|
|
PJS
|
[NCBI]
|
3.51498e-05
|
|
|
BCL6
|
[NCBI]
|
3.50902e-05
|
|
|
meningioma, familial
|
[NCBI]
|
3.50289e-05
|
|
|
CADASIL
|
[NCBI]
|
3.50289e-05
|
|
|
PCTT
|
[NCBI]
|
3.50289e-05
|
|
|
GTS
|
[NCBI]
|
3.49592e-05
|
|
|
MSH2
|
[NCBI]
|
3.48644e-05
|
|
|
MC2R
|
[NCBI]
|
3.44723e-05
|
|
|
MPL
|
[NCBI]
|
3.44723e-05
|
|
|
PLOD1
|
[NCBI]
|
3.44723e-05
|
|
|
glycogen storage disease i
|
[NCBI]
|
3.43704e-05
|
|
|
GP9
|
[NCBI]
|
3.42493e-05
|
|
|
CYP27A1
|
[NCBI]
|
3.42493e-05
|
|
|
MDM1
|
[NCBI]
|
3.42493e-05
|
|
|
GSS
|
[NCBI]
|
3.42493e-05
|
|
|
HK2
|
[NCBI]
|
3.42493e-05
|
|
|
FRAP1
|
[NCBI]
|
3.42101e-05
|
|
|
SHBG
|
[NCBI]
|
3.41193e-05
|
|
|
amyloidosis vi
|
[NCBI]
|
3.39463e-05
|
|
|
LCAT
|
[NCBI]
|
3.39074e-05
|
|
|
SHOX
|
[NCBI]
|
3.36729e-05
|
|
|
PTPRC
|
[NCBI]
|
3.36729e-05
|
|
|
CORD2
|
[NCBI]
|
3.36679e-05
|
|
|
SPG2
|
[NCBI]
|
3.36679e-05
|
|
|
FSHMD1A
|
[NCBI]
|
3.31146e-05
|
|
|
XDH
|
[NCBI]
|
3.296e-05
|
|
|
HBD
|
[NCBI]
|
3.27423e-05
|
|
|
FUT3
|
[NCBI]
|
3.25572e-05
|
|
|
neuraminidase deficiency
|
[NCBI]
|
3.25055e-05
|
|
|
ATS
|
[NCBI]
|
3.25055e-05
|
|
|
KCNQ1
|
[NCBI]
|
3.22393e-05
|
|
|
HP
|
[NCBI]
|
3.21083e-05
|
|
|
APRT
|
[NCBI]
|
3.20686e-05
|
|
|
PTHLH
|
[NCBI]
|
3.20483e-05
|
|
|
PF4
|
[NCBI]
|
3.20129e-05
|
|
|
camurati-engelmann disease
|
[NCBI]
|
3.17179e-05
|
|
|
SHEP2
|
[NCBI]
|
3.17179e-05
|
|
|
properdin deficiency, x-linked
|
[NCBI]
|
3.17179e-05
|
|
|
EAOH
|
[NCBI]
|
3.17179e-05
|
|
|
GABEB
|
[NCBI]
|
3.17179e-05
|
|
|
EGR2
|
[NCBI]
|
3.16095e-05
|
|
|
OXCT1
|
[NCBI]
|
3.15413e-05
|
|
|
SLC25A15
|
[NCBI]
|
3.15413e-05
|
|
|
GAN
|
[NCBI]
|
3.15413e-05
|
|
|
GLC1A
|
[NCBI]
|
3.13169e-05
|
|
|
NIDDM
|
[NCBI]
|
3.13096e-05
|
|
|
CAMT
|
[NCBI]
|
3.12771e-05
|
|
|
CORD6
|
[NCBI]
|
3.12771e-05
|
|
|
homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cble complementation type
|
[NCBI]
|
3.12771e-05
|
|
|
HHF4
|
[NCBI]
|
3.12771e-05
|
|
|
xanthinuria, type i
|
[NCBI]
|
3.12771e-05
|
|
|
retinitis pigmentosa-deafness syndrome
|
[NCBI]
|
3.12771e-05
|
|
|
leigh syndrome, x-linked
|
[NCBI]
|
3.12771e-05
|
|
|
pancreatic agenesis, congenital
|
[NCBI]
|
3.12771e-05
|
|
|
papilloma of choroid plexus
|
[NCBI]
|
3.12771e-05
|
|
|
charcot-marie-tooth disease, axonal, with vocal cord paresis, autosomal recessive
|
[NCBI]
|
3.12771e-05
|
|
|
nephrotic syndrome, early-onset, with diffuse mesangial sclerosis
|
[NCBI]
|
3.12771e-05
|
|
|
neuropathy, ataxia, and retinitis pigmentosa
|
[NCBI]
|
3.12771e-05
|
|
|
heterotaxy, visceral, 2, autosomal
|
[NCBI]
|
3.12771e-05
|
|
|
cervical cancer
|
[NCBI]
|
3.12771e-05
|
|
|
orofacial cleft 5
|
[NCBI]
|
3.12771e-05
|
|
|
laurence-moon syndrome
|
[NCBI]
|
3.12771e-05
|
|
|
ACG1B
|
[NCBI]
|
3.12771e-05
|
|
|
CDG1G
|
[NCBI]
|
3.12771e-05
|
|
|
CSNBAD1
|
[NCBI]
|
3.12771e-05
|
|
|
FHCA
|
[NCBI]
|
3.12771e-05
|
|
|
CMM3
|
[NCBI]
|
3.12771e-05
|
|
|
isobutyryl-coa dehydrogenase deficiency
|
[NCBI]
|
3.12771e-05
|
|
|
hyperoxaluria, primary, type ii
|
[NCBI]
|
3.12771e-05
|
|
|
complement component 4, partial deficiency of
|
[NCBI]
|
3.12771e-05
|
|
|
spongiform encephalopathy with neuropsychiatric features
|
[NCBI]
|
3.12771e-05
|
|
|
SW
|
[NCBI]
|
3.12771e-05
|
|
|
dyserythropoietic anemia with thrombocytopenia
|
[NCBI]
|
3.12771e-05
|
|
|
LGMD2K
|
[NCBI]
|
3.12771e-05
|
|
|
endocardial fibroelastosis
|
[NCBI]
|
3.12771e-05
|
|
|
LI3
|
[NCBI]
|
3.12771e-05
|
|
|
CLN7
|
[NCBI]
|
3.12771e-05
|
|
|
cortisol 11-beta-ketoreductase deficiency
|
[NCBI]
|
3.12639e-05
|
|
|
ACADM
|
[NCBI]
|
3.11525e-05
|
|
|
WBS
|
[NCBI]
|
3.11013e-05
|
|
|
mucopolysaccharidosis type iva
|
[NCBI]
|
3.10852e-05
|
|
|
TF
|
[NCBI]
|
3.09288e-05
|
|
|
MJD
|
[NCBI]
|
3.08004e-05
|
|
|
MTM1
|
[NCBI]
|
3.07437e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
3.06383e-05
|
|
|
HEXB
|
[NCBI]
|
3.04839e-05
|
|
|
GLA
|
[NCBI]
|
3.04839e-05
|
|
|
BRAF
|
[NCBI]
|
3.04839e-05
|
|
|
SVAS
|
[NCBI]
|
3.04441e-05
|
|
|
growth hormone insensitivity syndrome
|
[NCBI]
|
3.01735e-05
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
3.00243e-05
|
|
|
SLC22A5
|
[NCBI]
|
2.99163e-05
|
|
|
MVK
|
[NCBI]
|
2.99163e-05
|
|
|
CLN2
|
[NCBI]
|
2.99073e-05
|
|
|
acyl-coa dehydrogenase, very long-chain, deficiency of
|
[NCBI]
|
2.99073e-05
|
|
|
bethlem myopathy
|
[NCBI]
|
2.99073e-05
|
|
|
POLG
|
[NCBI]
|
2.98991e-05
|
|
|
CSF2RB
|
[NCBI]
|
2.96429e-05
|
|
|
ACAT1
|
[NCBI]
|
2.96429e-05
|
|
|
NCF2
|
[NCBI]
|
2.96429e-05
|
|
|
HLCS
|
[NCBI]
|
2.96429e-05
|
|
|
ABCC1
|
[NCBI]
|
2.9352e-05
|
|
|
RUNX1
|
[NCBI]
|
2.933e-05
|
|
|
hemophilia a
|
[NCBI]
|
2.91284e-05
|
|
|
CHRNE
|
[NCBI]
|
2.91243e-05
|
|
|
GJA8
|
[NCBI]
|
2.91243e-05
|
|
|
contractural arachnodactyly, congenital
|
[NCBI]
|
2.91243e-05
|
|
|
TIMP3
|
[NCBI]
|
2.91243e-05
|
|
|
GCCR
|
[NCBI]
|
2.89886e-05
|
|
|
AGXT
|
[NCBI]
|
2.8371e-05
|
|
|
CSF3R
|
[NCBI]
|
2.8371e-05
|
|
|
P2RX7
|
[NCBI]
|
2.8371e-05
|
|
|
NEFH
|
[NCBI]
|
2.8371e-05
|
|
|
BTD
|
[NCBI]
|
2.8371e-05
|
|
|
NF1
|
[NCBI]
|
2.83484e-05
|
|
|
TNFRSF6
|
[NCBI]
|
2.82366e-05
|
|
|
methemoglobinemia due to deficiency of methemoglobin reductase
|
[NCBI]
|
2.82366e-05
|
|
|
canavan disease
|
[NCBI]
|
2.82209e-05
|
|
|
epidermolysis bullosa letalis
|
[NCBI]
|
2.82209e-05
|
|
|
polycythemia vera
|
[NCBI]
|
2.82209e-05
|
|
|
MEN2B
|
[NCBI]
|
2.82209e-05
|
|
|
ICAP1
|
[NCBI]
|
2.81244e-05
|
|
|
AP1B1
|
[NCBI]
|
2.81244e-05
|
|
|
MTTL2
|
[NCBI]
|
2.81244e-05
|
|
|
FBP1
|
[NCBI]
|
2.81244e-05
|
|
|
AQP2
|
[NCBI]
|
2.77242e-05
|
|
|
TPMT
|
[NCBI]
|
2.73375e-05
|
|
|
PKD1
|
[NCBI]
|
2.73375e-05
|
|
|
TULP1
|
[NCBI]
|
2.71985e-05
|
|
|
SPG3A
|
[NCBI]
|
2.71985e-05
|
|
|
MADHIP
|
[NCBI]
|
2.71985e-05
|
|
|
MECP2
|
[NCBI]
|
2.71076e-05
|
|
|
HAE
|
[NCBI]
|
2.69917e-05
|
|
|
CSTB
|
[NCBI]
|
2.69363e-05
|
|
|
PGR
|
[NCBI]
|
2.68091e-05
|
|
|
hyperprolinemia, type ii
|
[NCBI]
|
2.66973e-05
|
|
|
RCD3A
|
[NCBI]
|
2.66973e-05
|
|
|
IDDM12
|
[NCBI]
|
2.66973e-05
|
|
|
RP7
|
[NCBI]
|
2.66973e-05
|
|
|
witkop syndrome
|
[NCBI]
|
2.66973e-05
|
|
|
OPTB5
|
[NCBI]
|
2.66973e-05
|
|
|
watson syndrome
|
[NCBI]
|
2.66973e-05
|
|
|
gtp cyclohydrolase i deficiency
|
[NCBI]
|
2.66973e-05
|
|
|
budd-chiari syndrome
|
[NCBI]
|
2.66973e-05
|
|
|
wildervanck syndrome
|
[NCBI]
|
2.66973e-05
|
|
|
cystinosis, late-onset juvenile or adolescent nephropathic type
|
[NCBI]
|
2.66973e-05
|
|
|
mitochondrial complex ii deficiency
|
[NCBI]
|
2.66973e-05
|
|
|
RCDP3
|
[NCBI]
|
2.66973e-05
|
|
|
PPCRA
|
[NCBI]
|
2.66973e-05
|
|
|
anemia, hypochromic microcytic
|
[NCBI]
|
2.66973e-05
|
|
|
NAIC
|
[NCBI]
|
2.66973e-05
|
|
|
LI2
|
[NCBI]
|
2.66973e-05
|
|
|
EBDSC
|
[NCBI]
|
2.66973e-05
|
|
|
weyers acrofacial dysostosis
|
[NCBI]
|
2.66973e-05
|
|
|
white sponge nevus of cannon
|
[NCBI]
|
2.66973e-05
|
|
|
spondylocarpotarsal synostosis syndrome
|
[NCBI]
|
2.66973e-05
|
|
|
epidermolysis bullosa pruriginosa
|
[NCBI]
|
2.66973e-05
|
|
|
tropical calcific pancreatitis
|
[NCBI]
|
2.66973e-05
|
|
|
3-@methylglutaconic aciduria, type iii
|
[NCBI]
|
2.66973e-05
|
|
|
cutis laxa, x-linked
|
[NCBI]
|
2.66461e-05
|
|
|
UCMD
|
[NCBI]
|
2.66461e-05
|
|
|
hyperoxaluria, primary, type i
|
[NCBI]
|
2.66461e-05
|
|
|
APL
|
[NCBI]
|
2.66461e-05
|
|
|
osteogenesis imperfecta, type iii
|
[NCBI]
|
2.66461e-05
|
|
|
CHS
|
[NCBI]
|
2.64875e-05
|
|
|
glycogen storage disease ii
|
[NCBI]
|
2.64371e-05
|
|
|
GCH1
|
[NCBI]
|
2.62627e-05
|
|
|
SLC26A2
|
[NCBI]
|
2.6112e-05
|
|
|
BEST1
|
[NCBI]
|
2.6112e-05
|
|
|
SLC19A1
|
[NCBI]
|
2.6112e-05
|
|
|
VMD
|
[NCBI]
|
2.60071e-05
|
|
|
PAX6
|
[NCBI]
|
2.57644e-05
|
|
|
SCN5A
|
[NCBI]
|
2.5735e-05
|
|
|
MTND1
|
[NCBI]
|
2.5735e-05
|
|
|
BANF1
|
[NCBI]
|
2.5614e-05
|
|
|
COL10A1
|
[NCBI]
|
2.5614e-05
|
|
|
ARMET
|
[NCBI]
|
2.5531e-05
|
|
|
MTTF
|
[NCBI]
|
2.5531e-05
|
|
|
HSD17B3
|
[NCBI]
|
2.5531e-05
|
|
|
UNG
|
[NCBI]
|
2.52703e-05
|
|
|
thrombocythemia, essential
|
[NCBI]
|
2.51717e-05
|
|
|
mucopolysaccharidosis type vi
|
[NCBI]
|
2.51717e-05
|
|
|
epidermolysis bullosa with pyloric atresia
|
[NCBI]
|
2.51717e-05
|
|
|
CRX
|
[NCBI]
|
2.51007e-05
|
|
|
KEL
|
[NCBI]
|
2.51007e-05
|
|
|
TAZ
|
[NCBI]
|
2.51007e-05
|
|
|
C7
|
[NCBI]
|
2.51007e-05
|
|
|
APOBEC3G
|
[NCBI]
|
2.51007e-05
|
|
|
CTGF
|
[NCBI]
|
2.48662e-05
|
|
|
ABL1
|
[NCBI]
|
2.48164e-05
|
|
|
BWS
|
[NCBI]
|
2.44222e-05
|
|
|
GLB1
|
[NCBI]
|
2.43851e-05
|
|
|
CBD
|
[NCBI]
|
2.43851e-05
|
|
|
TPM3
|
[NCBI]
|
2.41556e-05
|
|
|
CBP
|
[NCBI]
|
2.41556e-05
|
|
|
ADSL
|
[NCBI]
|
2.41556e-05
|
|
|
GLDC
|
[NCBI]
|
2.41556e-05
|
|
|
DYT1
|
[NCBI]
|
2.41412e-05
|
|
|
MAG
|
[NCBI]
|
2.40139e-05
|
|
|
otopetrin 3
|
[NCBI]
|
2.39097e-05
|
|
|
otopetrin 1
|
[NCBI]
|
2.39097e-05
|
|
|
udp-glucose:glycoprotein glucosyltransferase 1
|
[NCBI]
|
2.39097e-05
|
|
|
otopetrin 2
|
[NCBI]
|
2.39097e-05
|
|
|
udp-glucose:glycoprotein glucosyltransferase 2
|
[NCBI]
|
2.39097e-05
|
|
|
MTTT
|
[NCBI]
|
2.39097e-05
|
|
|
OR1F1
|
[NCBI]
|
2.39097e-05
|
|
|
TRAPPC1
|
[NCBI]
|
2.39097e-05
|
|
|
SIRPB1
|
[NCBI]
|
2.39097e-05
|
|
|
RAXL1
|
[NCBI]
|
2.39097e-05
|
|
|
KLHL3
|
[NCBI]
|
2.39097e-05
|
|
|
PRNPIP
|
[NCBI]
|
2.39097e-05
|
|
|
IHPK3
|
[NCBI]
|
2.39097e-05
|
|
|
PIGA
|
[NCBI]
|
2.38024e-05
|
|
|
aspartylglucosaminuria
|
[NCBI]
|
2.38024e-05
|
|
|
EKV
|
[NCBI]
|
2.37886e-05
|
|
|
CLN1
|
[NCBI]
|
2.37886e-05
|
|
|
glycogen storage disease iii
|
[NCBI]
|
2.37886e-05
|
|
|
myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency
|
[NCBI]
|
2.37886e-05
|
|
|
GNRHR
|
[NCBI]
|
2.35158e-05
|
|
|
TRMU
|
[NCBI]
|
2.34447e-05
|
|
|
C1QG
|
[NCBI]
|
2.34447e-05
|
|
|
PDE6G
|
[NCBI]
|
2.34447e-05
|
|
|
ARFIP2
|
[NCBI]
|
2.34447e-05
|
|
|
MBL2
|
[NCBI]
|
2.34293e-05
|
|
|
HADHA
|
[NCBI]
|
2.32693e-05
|
|
|
GUCY2D
|
[NCBI]
|
2.32693e-05
|
|
|
EP300
|
[NCBI]
|
2.32693e-05
|
|
|
thyroid carcinoma, papillary
|
[NCBI]
|
2.32567e-05
|
|
|
coproporphyria
|
[NCBI]
|
2.32391e-05
|
|
|
PTHR1
|
[NCBI]
|
2.32391e-05
|
|
|
bartter syndrome, infantile, with sensorineural deafness
|
[NCBI]
|
2.31456e-05
|
|
|
methylmalonic aciduria, cbla type
|
[NCBI]
|
2.31456e-05
|
|
|
PRTH
|
[NCBI]
|
2.31456e-05
|
|
|
uniparental disomy, paternal, chromosome 14
|
[NCBI]
|
2.31456e-05
|
|
|
mannosidosis, beta a, lysosomal
|
[NCBI]
|
2.31456e-05
|
|
|
frasier syndrome
|
[NCBI]
|
2.31456e-05
|
|
|
SMDP2
|
[NCBI]
|
2.31456e-05
|
|
|
basal ganglia disease, adult-onset
|
[NCBI]
|
2.31456e-05
|
|
|
ceroid lipofuscinosis, neuronal, 8, northern epilepsy variant
|
[NCBI]
|
2.31456e-05
|
|
|
boomerang dysplasia
|
[NCBI]
|
2.31456e-05
|
|
|
enchondromatosis, multiple
|
[NCBI]
|
2.31456e-05
|
|
|
arthrogryposis, renal dysfunction, and cholestasis
|
[NCBI]
|
2.31456e-05
|
|
|
CMD1E
|
[NCBI]
|
2.31456e-05
|
|
|
erythroleukemia, familial
|
[NCBI]
|
2.31456e-05
|
|
|
gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to
|
[NCBI]
|
2.31456e-05
|
|
|
patterned dystrophy of retinal pigment epithelium
|
[NCBI]
|
2.31456e-05
|
|
|
naxos disease
|
[NCBI]
|
2.31456e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-negative
|
[NCBI]
|
2.31456e-05
|
|
|
nasopharyngeal carcinoma
|
[NCBI]
|
2.31456e-05
|
|
|
corneal dystrophy, epithelial basement membrane
|
[NCBI]
|
2.31456e-05
|
|
|
BDA2
|
[NCBI]
|
2.31456e-05
|
|
|
minicore myopathy with external ophthalmoplegia
|
[NCBI]
|
2.31456e-05
|
|
|
tyrosinemia, type iii
|
[NCBI]
|
2.31456e-05
|
|
|
myopathy, centronuclear, autosomal dominant
|
[NCBI]
|
2.31456e-05
|
|
|
ACADS
|
[NCBI]
|
2.26942e-05
|
|
|
XPA
|
[NCBI]
|
2.26942e-05
|
|
|
MTCO1
|
[NCBI]
|
2.26942e-05
|
|
|
SOD2
|
[NCBI]
|
2.25811e-05
|
|
|
POMC
|
[NCBI]
|
2.25336e-05
|
|
|
myopathy, myofibrillar, desmin-related
|
[NCBI]
|
2.24885e-05
|
|
|
CACNA1S
|
[NCBI]
|
2.24356e-05
|
|
|
DBT
|
[NCBI]
|
2.24356e-05
|
|
|
phenylketonuria ii
|
[NCBI]
|
2.24356e-05
|
|
|
IGF1
|
[NCBI]
|
2.22993e-05
|
|
|
wolman disease
|
[NCBI]
|
2.21668e-05
|
|
|
WT1
|
[NCBI]
|
2.1911e-05
|
|
|
AS
|
[NCBI]
|
2.18077e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
2.18077e-05
|
|
|
NLGN3
|
[NCBI]
|
2.17036e-05
|
|
|
PCBD1
|
[NCBI]
|
2.17036e-05
|
|
|
CUL2
|
[NCBI]
|
2.17036e-05
|
|
|
EED
|
[NCBI]
|
2.17036e-05
|
|
|
SLC10A2
|
[NCBI]
|
2.17036e-05
|
|
|
EDNRB
|
[NCBI]
|
2.16559e-05
|
|
|
XK
|
[NCBI]
|
2.16492e-05
|
|
|
FLT3
|
[NCBI]
|
2.16492e-05
|
|
|
GJB6
|
[NCBI]
|
2.16492e-05
|
|
|
gaucher disease, type iii
|
[NCBI]
|
2.12643e-05
|
|
|
NEM3
|
[NCBI]
|
2.12643e-05
|
|
|
AHC
|
[NCBI]
|
2.12643e-05
|
|
|
CYP19A1
|
[NCBI]
|
2.11587e-05
|
|
|
EBP
|
[NCBI]
|
2.09055e-05
|
|
|
HNPP
|
[NCBI]
|
2.07804e-05
|
|
|
mitochondrial myopathy with diabetes
|
[NCBI]
|
2.02732e-05
|
|
|
hand-foot-uterus syndrome
|
[NCBI]
|
2.02732e-05
|
|
|
sulfocysteinuria
|
[NCBI]
|
2.02732e-05
|
|
|
CLN6
|
[NCBI]
|
2.02732e-05
|
|
|
STHAG3
|
[NCBI]
|
2.02732e-05
|
|
|
vater association
|
[NCBI]
|
2.02732e-05
|
|
|
MPD1
|
[NCBI]
|
2.02732e-05
|
|
|
short stature, idiopathic, autosomal
|
[NCBI]
|
2.02732e-05
|
|
|
hyperthyroidism, nonautoimmune
|
[NCBI]
|
2.02732e-05
|
|
|
ichthyosis, bullous type
|
[NCBI]
|
2.02732e-05
|
|
|
foveal hypoplasia and presenile cataract syndrome
|
[NCBI]
|
2.02732e-05
|
|
|
LGMD1C
|
[NCBI]
|
2.02732e-05
|
|
|
avascular necrosis of femoral head, primary
|
[NCBI]
|
2.02732e-05
|
|
|
polymicrogyria, bilateral frontoparietal
|
[NCBI]
|
2.02732e-05
|
|
|
AOII
|
[NCBI]
|
2.02732e-05
|
|
|
amme complex
|
[NCBI]
|
2.02732e-05
|
|
|
CPVT
|
[NCBI]
|
2.02732e-05
|
|
|
CORD3
|
[NCBI]
|
2.02732e-05
|
|
|
drug metabolism, poor, cyp2c19-related
|
[NCBI]
|
2.02732e-05
|
|
|
aplastic anemia
|
[NCBI]
|
2.02732e-05
|
|
|
CZP3
|
[NCBI]
|
2.02732e-05
|
|
|
radioulnar synostosis
|
[NCBI]
|
2.02732e-05
|
|
|
ABCA4
|
[NCBI]
|
2.02144e-05
|
|
|
PEX13
|
[NCBI]
|
2.0213e-05
|
|
|
GP1BB
|
[NCBI]
|
2.0213e-05
|
|
|
LAMC2
|
[NCBI]
|
2.0213e-05
|
|
|
MTRR
|
[NCBI]
|
2.0213e-05
|
|
|
NR3C2
|
[NCBI]
|
2.02007e-05
|
|
|
maple syrup urine disease
|
[NCBI]
|
2.00099e-05
|
|
|
HD
|
[NCBI]
|
1.97402e-05
|
|
|
MSX1
|
[NCBI]
|
1.95313e-05
|
|
|
EDA
|
[NCBI]
|
1.95313e-05
|
|
|
CYP11B1
|
[NCBI]
|
1.95313e-05
|
|
|
CVID
|
[NCBI]
|
1.93323e-05
|
|
|
CYP17A1
|
[NCBI]
|
1.93222e-05
|
|
|
CLS
|
[NCBI]
|
1.9265e-05
|
|
|
FHM1
|
[NCBI]
|
1.90199e-05
|
|
|
mucopolysaccharidosis type vii
|
[NCBI]
|
1.90199e-05
|
|
|
EVC
|
[NCBI]
|
1.90199e-05
|
|
|
GUCA1A
|
[NCBI]
|
1.89128e-05
|
|
|
SCN1B
|
[NCBI]
|
1.89128e-05
|
|
|
PHKA1
|
[NCBI]
|
1.89128e-05
|
|
|
KRT2A
|
[NCBI]
|
1.89128e-05
|
|
|
ACVR1
|
[NCBI]
|
1.89128e-05
|
|
|
farber lipogranulomatosis
|
[NCBI]
|
1.89128e-05
|
|
|
PHYH
|
[NCBI]
|
1.89128e-05
|
|
|
LMAN1
|
[NCBI]
|
1.89128e-05
|
|
|
FKRP
|
[NCBI]
|
1.88944e-05
|
|
|
MTCO3
|
[NCBI]
|
1.88944e-05
|
|
|
LEPR
|
[NCBI]
|
1.85788e-05
|
|
|
ATRX
|
[NCBI]
|
1.84794e-05
|
|
|
EXT1
|
[NCBI]
|
1.82874e-05
|
|
|
IL2RG
|
[NCBI]
|
1.82874e-05
|
|
|
factor x deficiency
|
[NCBI]
|
1.80751e-05
|
|
|
EPPK
|
[NCBI]
|
1.78837e-05
|
|
|
TRMA
|
[NCBI]
|
1.78837e-05
|
|
|
CHED2
|
[NCBI]
|
1.78837e-05
|
|
|
rheumatoid arthritis, systemic juvenile
|
[NCBI]
|
1.78837e-05
|
|
|
SANDO
|
[NCBI]
|
1.78837e-05
|
|
|
chondrodysplasia, grebe type
|
[NCBI]
|
1.78837e-05
|
|
|
CDG1B
|
[NCBI]
|
1.78837e-05
|
|
|
de sanctis-cacchione syndrome
|
[NCBI]
|
1.78837e-05
|
|
|
PGL4
|
[NCBI]
|
1.78837e-05
|
|
|
SC
|
[NCBI]
|
1.78837e-05
|
|
|
AOI
|
[NCBI]
|
1.78837e-05
|
|
|
deafness, aminoglycoside-induced
|
[NCBI]
|
1.78837e-05
|
|
|
aceruloplasminemia
|
[NCBI]
|
1.78837e-05
|
|
|
hermaphroditism, true
|
[NCBI]
|
1.78837e-05
|
|
|
citrullinemia, type ii, neonatal-onset
|
[NCBI]
|
1.78837e-05
|
|
|
myopathy, myosin storage
|
[NCBI]
|
1.78837e-05
|
|
|
colorectal adenomatous polyposis, autosomal recessive
|
[NCBI]
|
1.78837e-05
|
|
|
VMCM
|
[NCBI]
|
1.78837e-05
|
|
|
ODG2
|
[NCBI]
|
1.78837e-05
|
|
|
epilepsy, nocturnal frontal lobe, type 1
|
[NCBI]
|
1.78837e-05
|
|
|
congenital hemidysplasia with ichthyosiform erythroderma and limb defects
|
[NCBI]
|
1.78837e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 3
|
[NCBI]
|
1.78837e-05
|
|
|
HESX1
|
[NCBI]
|
1.77624e-05
|
|
|
SECISBP2
|
[NCBI]
|
1.77624e-05
|
|
|
COL5A2
|
[NCBI]
|
1.77624e-05
|
|
|
LAMA3
|
[NCBI]
|
1.77624e-05
|
|
|
ATP2B2
|
[NCBI]
|
1.77624e-05
|
|
|
CFD
|
[NCBI]
|
1.77624e-05
|
|
|
C1QA
|
[NCBI]
|
1.77624e-05
|
|
|
OPA1
|
[NCBI]
|
1.77079e-05
|
|
|
BCNS
|
[NCBI]
|
1.74296e-05
|
|
|
NTRK1
|
[NCBI]
|
1.72985e-05
|
|
|
PRF1
|
[NCBI]
|
1.72985e-05
|
|
|
TNNT2
|
[NCBI]
|
1.7154e-05
|
|
|
PROP1
|
[NCBI]
|
1.7154e-05
|
|
|
MUT
|
[NCBI]
|
1.7154e-05
|
|
|
ITGA2B
|
[NCBI]
|
1.7154e-05
|
|
|
PCD
|
[NCBI]
|
1.71106e-05
|
|
|
LAM
|
[NCBI]
|
1.71106e-05
|
|
|
apert syndrome
|
[NCBI]
|
1.70136e-05
|
|
|
MYO15A
|
[NCBI]
|
1.67327e-05
|
|
|
ARG1
|
[NCBI]
|
1.67327e-05
|
|
|
KRT17
|
[NCBI]
|
1.67327e-05
|
|
|
COL4A4
|
[NCBI]
|
1.67327e-05
|
|
|
PAX9
|
[NCBI]
|
1.67327e-05
|
|
|
TIMM8A
|
[NCBI]
|
1.67327e-05
|
|
|
POU3F4
|
[NCBI]
|
1.67327e-05
|
|
|
TRIM24
|
[NCBI]
|
1.67327e-05
|
|
|
TTPA
|
[NCBI]
|
1.67327e-05
|
|
|
C10ORF2
|
[NCBI]
|
1.67327e-05
|
|
|
TNFSF10
|
[NCBI]
|
1.66695e-05
|
|
|
SMPD1
|
[NCBI]
|
1.66237e-05
|
|
|
ARSB
|
[NCBI]
|
1.66237e-05
|
|
|
RASA1
|
[NCBI]
|
1.64094e-05
|
|
|
PROS1
|
[NCBI]
|
1.61155e-05
|
|
|
TSHR
|
[NCBI]
|
1.61007e-05
|
|
|
homocysteinemia
|
[NCBI]
|
1.60892e-05
|
|
|
RP3
|
[NCBI]
|
1.60892e-05
|
|
|
fundus albipunctatus
|
[NCBI]
|
1.58553e-05
|
|
|
HFE3
|
[NCBI]
|
1.58553e-05
|
|
|
gitelman syndrome
|
[NCBI]
|
1.58553e-05
|
|
|
SYNS1
|
[NCBI]
|
1.58553e-05
|
|
|
BOCD
|
[NCBI]
|
1.58553e-05
|
|
|
vitamin k-dependent clotting factors, combined deficiency of, 1
|
[NCBI]
|
1.58553e-05
|
|
|
SPG10
|
[NCBI]
|
1.58553e-05
|
|
|
morquio syndrome b
|
[NCBI]
|
1.58553e-05
|
|
|
NSHPT
|
[NCBI]
|
1.58553e-05
|
|
|
HMN2A
|
[NCBI]
|
1.58553e-05
|
|
|
RP12
|
[NCBI]
|
1.58553e-05
|
|
|
DFNA9
|
[NCBI]
|
1.58553e-05
|
|
|
ADHR
|
[NCBI]
|
1.58553e-05
|
|
|
complement factor i deficiency
|
[NCBI]
|
1.58553e-05
|
|
|
DDD
|
[NCBI]
|
1.58553e-05
|
|
|
LRS1
|
[NCBI]
|
1.58553e-05
|
|
|
corticosteroid-binding globulin deficiency
|
[NCBI]
|
1.58553e-05
|
|
|
SNCA
|
[NCBI]
|
1.58318e-05
|
|
|
COL6A2
|
[NCBI]
|
1.58026e-05
|
|
|
PRKAG2
|
[NCBI]
|
1.58026e-05
|
|
|
BLNK
|
[NCBI]
|
1.58026e-05
|
|
|
KRT8
|
[NCBI]
|
1.58026e-05
|
|
|
HTATSF1
|
[NCBI]
|
1.577e-05
|
|
|
selenoprotein translation factor selb
|
[NCBI]
|
1.577e-05
|
|
|
GPR92
|
[NCBI]
|
1.577e-05
|
|
|
PELI3
|
[NCBI]
|
1.577e-05
|
|
|
RRAS2
|
[NCBI]
|
1.577e-05
|
|
|
TGFBRAP1
|
[NCBI]
|
1.577e-05
|
|
|
PLA2G3
|
[NCBI]
|
1.577e-05
|
|
|
TOR2A
|
[NCBI]
|
1.577e-05
|
|
|
MMAA
|
[NCBI]
|
1.577e-05
|
|
|
PRKAG3
|
[NCBI]
|
1.577e-05
|
|
|
TRIM23
|
[NCBI]
|
1.577e-05
|
|
|
CPA6
|
[NCBI]
|
1.577e-05
|
|
|
PRCD
|
[NCBI]
|
1.577e-05
|
|
|
ARSF
|
[NCBI]
|
1.577e-05
|
|
|
mapbp-interacting protein
|
[NCBI]
|
1.577e-05
|
|
|
TPM4
|
[NCBI]
|
1.577e-05
|
|
|
transcription termination factor, mitochondrial
|
[NCBI]
|
1.577e-05
|
|
|
PPP2R5A
|
[NCBI]
|
1.577e-05
|
|
|
OPA3
|
[NCBI]
|
1.577e-05
|
|
|
RPGRIP1L
|
[NCBI]
|
1.577e-05
|
|
|
selenophosphate synthetase 1
|
[NCBI]
|
1.577e-05
|
|
|
CTTNBP2
|
[NCBI]
|
1.577e-05
|
|
|
TOR1B
|
[NCBI]
|
1.577e-05
|
|
|
EDN3
|
[NCBI]
|
1.56279e-05
|
|
|
CAV3
|
[NCBI]
|
1.56279e-05
|
|
|
MTR
|
[NCBI]
|
1.55677e-05
|
|
|
LQT1
|
[NCBI]
|
1.52795e-05
|
|
|
IGF1R
|
[NCBI]
|
1.51595e-05
|
|
|
glycogen storage disease ixa
|
[NCBI]
|
1.51595e-05
|
|
|
MET
|
[NCBI]
|
1.51595e-05
|
|
|
ALDH3A2
|
[NCBI]
|
1.51595e-05
|
|
|
COL6A1
|
[NCBI]
|
1.51595e-05
|
|
|
SMAD4
|
[NCBI]
|
1.51595e-05
|
|
|
MTP
|
[NCBI]
|
1.4956e-05
|
|
|
SDHC
|
[NCBI]
|
1.4956e-05
|
|
|
MAT1A
|
[NCBI]
|
1.4956e-05
|
|
|
MSX2
|
[NCBI]
|
1.4956e-05
|
|
|
NQO1
|
[NCBI]
|
1.4956e-05
|
|
|
PRPS1
|
[NCBI]
|
1.4956e-05
|
|
|
HOS
|
[NCBI]
|
1.46881e-05
|
|
|
PSEN2
|
[NCBI]
|
1.45606e-05
|
|
|
DMD
|
[NCBI]
|
1.45411e-05
|
|
|
ACE
|
[NCBI]
|
1.44981e-05
|
|
|
FCHL
|
[NCBI]
|
1.43804e-05
|
|
|
AMH
|
[NCBI]
|
1.43071e-05
|
|
|
SOX10
|
[NCBI]
|
1.42757e-05
|
|
|
CYBB
|
[NCBI]
|
1.42757e-05
|
|
|
HEMB
|
[NCBI]
|
1.41912e-05
|
|
|
TBXA2R
|
[NCBI]
|
1.41805e-05
|
|
|
RHAG
|
[NCBI]
|
1.41805e-05
|
|
|
TECTA
|
[NCBI]
|
1.41805e-05
|
|
|
AGTR2
|
[NCBI]
|
1.41805e-05
|
|
|
CRYGD
|
[NCBI]
|
1.41805e-05
|
|
|
CDK2
|
[NCBI]
|
1.41343e-05
|
|
|
PARK1
|
[NCBI]
|
1.4107e-05
|
|
|
17-@beta hydroxysteroid dehydrogenase iii deficiency
|
[NCBI]
|
1.4107e-05
|
|
|
hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
|
[NCBI]
|
1.4107e-05
|
|
|
alzheimer disease 4
|
[NCBI]
|
1.4107e-05
|
|
|
HFE4
|
[NCBI]
|
1.4107e-05
|
|
|
afibrinogenemia, congenital
|
[NCBI]
|
1.4107e-05
|
|
|
lymphedema, hereditary, i
|
[NCBI]
|
1.4107e-05
|
|
|
JWS
|
[NCBI]
|
1.4107e-05
|
|
|
argininemia
|
[NCBI]
|
1.4107e-05
|
|
|
epstein syndrome
|
[NCBI]
|
1.4107e-05
|
|
|
SCN3
|
[NCBI]
|
1.4107e-05
|
|
|
spinocerebellar ataxia, 16q22-linked
|
[NCBI]
|
1.4107e-05
|
|
|
alport syndrome, autosomal recessive
|
[NCBI]
|
1.4107e-05
|
|
|
spondyloepimetaphyseal dysplasia, strudwick type
|
[NCBI]
|
1.4107e-05
|
|
|
PBT
|
[NCBI]
|
1.4107e-05
|
|
|
FMD
|
[NCBI]
|
1.4107e-05
|
|
|
EV
|
[NCBI]
|
1.36973e-05
|
|
|
PARK2
|
[NCBI]
|
1.35902e-05
|
|
|
KCNQ2
|
[NCBI]
|
1.34661e-05
|
|
|
PFC
|
[NCBI]
|
1.34661e-05
|
|
|
CRB1
|
[NCBI]
|
1.34661e-05
|
|
|
SDHB
|
[NCBI]
|
1.34661e-05
|
|
|
oncogene dj1
|
[NCBI]
|
1.34661e-05
|
|
|
POMT1
|
[NCBI]
|
1.34661e-05
|
|
|
CERK
|
[NCBI]
|
1.34661e-05
|
|
|
GDF5
|
[NCBI]
|
1.34558e-05
|
|
|
ALB
|
[NCBI]
|
1.33799e-05
|
|
|
fabry disease
|
[NCBI]
|
1.324e-05
|
|
|
CTCF
|
[NCBI]
|
1.30676e-05
|
|
|
PHEX
|
[NCBI]
|
1.30676e-05
|
|
|
SERPINA6
|
[NCBI]
|
1.30188e-05
|
|
|
VDR
|
[NCBI]
|
1.30008e-05
|
|
|
CML
|
[NCBI]
|
1.28391e-05
|
|
|
EVA
|
[NCBI]
|
1.28391e-05
|
|
|
CAMK2A
|
[NCBI]
|
1.2805e-05
|
|
|
LRAT
|
[NCBI]
|
1.2805e-05
|
|
|
PCSK1
|
[NCBI]
|
1.2805e-05
|
|
|
ANGPT1
|
[NCBI]
|
1.2805e-05
|
|
|
NPHS1
|
[NCBI]
|
1.2805e-05
|
|
|
RAPSN
|
[NCBI]
|
1.2805e-05
|
|
|
HERC2
|
[NCBI]
|
1.27649e-05
|
|
|
MYH14
|
[NCBI]
|
1.27649e-05
|
|
|
ectodysplasin receptor, x-linked
|
[NCBI]
|
1.27649e-05
|
|
|
HS1BP3
|
[NCBI]
|
1.27649e-05
|
|
|
NDUFA8
|
[NCBI]
|
1.27649e-05
|
|
|
PTPRH
|
[NCBI]
|
1.27649e-05
|
|
|
DMGDH
|
[NCBI]
|
1.27649e-05
|
|
|
NDUFS7
|
[NCBI]
|
1.27649e-05
|
|
|
HOXA11
|
[NCBI]
|
1.27649e-05
|
|
|
nucleoporin, 210-kd
|
[NCBI]
|
1.27649e-05
|
|
|
CENTB1
|
[NCBI]
|
1.27649e-05
|
|
|
human endogenous retrovirus frd envelope protein
|
[NCBI]
|
1.27649e-05
|
|
|
PDE6H
|
[NCBI]
|
1.27649e-05
|
|
|
ZNF200
|
[NCBI]
|
1.27649e-05
|
|
|
PPP2R5C
|
[NCBI]
|
1.27649e-05
|
|
|
PEX10
|
[NCBI]
|
1.27649e-05
|
|
|
vesicle amine transport protein 1
|
[NCBI]
|
1.27649e-05
|
|
|
TAAR2
|
[NCBI]
|
1.27649e-05
|
|
|
AMPD3
|
[NCBI]
|
1.27649e-05
|
|
|
DMRT2
|
[NCBI]
|
1.27649e-05
|
|
|
MTTR
|
[NCBI]
|
1.27649e-05
|
|
|
HYAL3
|
[NCBI]
|
1.27649e-05
|
|
|
BCL11B
|
[NCBI]
|
1.27649e-05
|
|
|
DIRAS3
|
[NCBI]
|
1.27649e-05
|
|
|
ARFIP1
|
[NCBI]
|
1.27649e-05
|
|
|
ARF5
|
[NCBI]
|
1.27649e-05
|
|
|
PORCN
|
[NCBI]
|
1.27649e-05
|
|
|
ALG9
|
[NCBI]
|
1.27649e-05
|
|
|
MMSDH
|
[NCBI]
|
1.27649e-05
|
|
|
actin-binding protein, 34-kd
|
[NCBI]
|
1.27649e-05
|
|
|
kiaa1199
|
[NCBI]
|
1.27649e-05
|
|
|
ANP32C
|
[NCBI]
|
1.27649e-05
|
|
|
PI12
|
[NCBI]
|
1.27649e-05
|
|
|
SPRR1B
|
[NCBI]
|
1.27649e-05
|
|
|
POMT2
|
[NCBI]
|
1.27649e-05
|
|
|
BARX2
|
[NCBI]
|
1.27649e-05
|
|
|
DCP1A
|
[NCBI]
|
1.27649e-05
|
|
|
HLA-DO
|
[NCBI]
|
1.27649e-05
|
|
|
SEZ6L
|
[NCBI]
|
1.27649e-05
|
|
|
CACNA2D4
|
[NCBI]
|
1.27649e-05
|
|
|
PDCD10
|
[NCBI]
|
1.27649e-05
|
|
|
WDR36
|
[NCBI]
|
1.27649e-05
|
|
|
MIRN27B
|
[NCBI]
|
1.27649e-05
|
|
|
PPP2R5B
|
[NCBI]
|
1.27649e-05
|
|
|
MTTS2
|
[NCBI]
|
1.27649e-05
|
|
|
APOC2
|
[NCBI]
|
1.26927e-05
|
|
|
ALDH2
|
[NCBI]
|
1.26927e-05
|
|
|
ASPA
|
[NCBI]
|
1.26927e-05
|
|
|
metachromatic leukodystrophy due to saposin b deficiency
|
[NCBI]
|
1.25826e-05
|
|
|
platelet glycoprotein iv deficiency
|
[NCBI]
|
1.25826e-05
|
|
|
HSS
|
[NCBI]
|
1.25826e-05
|
|
|
MCOPS3
|
[NCBI]
|
1.25826e-05
|
|
|
ehlers-danlos syndrome, type ii
|
[NCBI]
|
1.25826e-05
|
|
|
gracile syndrome
|
[NCBI]
|
1.25826e-05
|
|
|
CMT2A2
|
[NCBI]
|
1.25826e-05
|
|
|
SPG6
|
[NCBI]
|
1.25826e-05
|
|
|
PFHB1A
|
[NCBI]
|
1.25826e-05
|
|
|
myeloma, multiple
|
[NCBI]
|
1.25826e-05
|
|
|
BDA1
|
[NCBI]
|
1.25826e-05
|
|
|
SCAR1
|
[NCBI]
|
1.25826e-05
|
|
|
BDB1
|
[NCBI]
|
1.25826e-05
|
|
|
brody myopathy
|
[NCBI]
|
1.25826e-05
|
|
|
SCA14
|
[NCBI]
|
1.25826e-05
|
|
|
HTX1
|
[NCBI]
|
1.25826e-05
|
|
|
scheie syndrome
|
[NCBI]
|
1.25826e-05
|
|
|
IRS1
|
[NCBI]
|
1.25579e-05
|
|
|
MEN1
|
[NCBI]
|
1.2515e-05
|
|
|
CHH
|
[NCBI]
|
1.25046e-05
|
|
|
IP
|
[NCBI]
|
1.25036e-05
|
|
|
WT1
|
[NCBI]
|
1.2403e-05
|
|
|
RS1
|
[NCBI]
|
1.23306e-05
|
|
|
ELN
|
[NCBI]
|
1.22967e-05
|
|
|
orotic aciduria i
|
[NCBI]
|
1.21906e-05
|
|
|
GABRG2
|
[NCBI]
|
1.21906e-05
|
|
|
SLC16A2
|
[NCBI]
|
1.21906e-05
|
|
|
SCNN1B
|
[NCBI]
|
1.21906e-05
|
|
|
BRCA1
|
[NCBI]
|
1.2152e-05
|
|
|
HIGM1
|
[NCBI]
|
1.21248e-05
|
|
|
CDPX2
|
[NCBI]
|
1.21248e-05
|
|
|
XLP1
|
[NCBI]
|
1.21248e-05
|
|
|
mitochondrial complex i deficiency
|
[NCBI]
|
1.21248e-05
|
|
|
CLL
|
[NCBI]
|
1.21248e-05
|
|
|
walker-warburg syndrome
|
[NCBI]
|
1.21248e-05
|
|
|
TGFB1
|
[NCBI]
|
1.20411e-05
|
|
|
EPOR
|
[NCBI]
|
1.20383e-05
|
|
|
PPT1
|
[NCBI]
|
1.19806e-05
|
|
|
SLC1A2
|
[NCBI]
|
1.19806e-05
|
|
|
CPE
|
[NCBI]
|
1.18988e-05
|
|
|
SDC2
|
[NCBI]
|
1.17501e-05
|
|
|
STK11
|
[NCBI]
|
1.1642e-05
|
|
|
UMOD
|
[NCBI]
|
1.1642e-05
|
|
|
fucosidosis
|
[NCBI]
|
1.1642e-05
|
|
|
CNTF
|
[NCBI]
|
1.16225e-05
|
|
|
HLF
|
[NCBI]
|
1.16176e-05
|
|
|
GJA3
|
[NCBI]
|
1.16176e-05
|
|
|
BHMT
|
[NCBI]
|
1.16176e-05
|
|
|
ACADVL
|
[NCBI]
|
1.16176e-05
|
|
|
NEFL
|
[NCBI]
|
1.16176e-05
|
|
|
ITGB4
|
[NCBI]
|
1.16176e-05
|
|
|
FOXC1
|
[NCBI]
|
1.16176e-05
|
|
|
HSD17B4
|
[NCBI]
|
1.16176e-05
|
|
|
EPB42
|
[NCBI]
|
1.16176e-05
|
|
|
TFPI
|
[NCBI]
|
1.15109e-05
|
|
|
MEB
|
[NCBI]
|
1.14453e-05
|
|
|
protoporphyria, erythropoietic
|
[NCBI]
|
1.13144e-05
|
|
|
SIRT1
|
[NCBI]
|
1.13144e-05
|
|
|
SHH
|
[NCBI]
|
1.12831e-05
|
|
|
von willebrand disease, recessive form
|
[NCBI]
|
1.12412e-05
|
|
|
encephalopathy, neonatal severe, due to mecp2 mutations
|
[NCBI]
|
1.12412e-05
|
|
|
gaucher disease, type ii
|
[NCBI]
|
1.12412e-05
|
|
|
PMDS
|
[NCBI]
|
1.12412e-05
|
|
|
sertoli cell-only syndrome, y-linked
|
[NCBI]
|
1.12412e-05
|
|
|
CLN5
|
[NCBI]
|
1.12412e-05
|
|
|
apolipoprotein c-ii deficiency
|
[NCBI]
|
1.12412e-05
|
|
|
RHS
|
[NCBI]
|
1.12412e-05
|
|
|
HPE2
|
[NCBI]
|
1.12412e-05
|
|
|
medulloblastoma
|
[NCBI]
|
1.12412e-05
|
|
|
SACS
|
[NCBI]
|
1.12412e-05
|
|
|
methylmalonic aciduria and homocystinuria, cblc type
|
[NCBI]
|
1.12412e-05
|
|
|
LIS1
|
[NCBI]
|
1.12412e-05
|
|
|
renal cysts and diabetes syndrome
|
[NCBI]
|
1.12412e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, late-onset
|
[NCBI]
|
1.12412e-05
|
|
|
CMT2B
|
[NCBI]
|
1.12412e-05
|
|
|
G6PT1
|
[NCBI]
|
1.10815e-05
|
|
|
LMX1B
|
[NCBI]
|
1.10815e-05
|
|
|
FUT2
|
[NCBI]
|
1.10815e-05
|
|
|
PRKCG
|
[NCBI]
|
1.10815e-05
|
|
|
PCCB
|
[NCBI]
|
1.10815e-05
|
|
|
SLC6A4
|
[NCBI]
|
1.10416e-05
|
|
|
TFR2
|
[NCBI]
|
1.09971e-05
|
|
|
DLST
|
[NCBI]
|
1.08512e-05
|
|
|
DPH2
|
[NCBI]
|
1.08512e-05
|
|
|
IRS4
|
[NCBI]
|
1.08512e-05
|
|
|
NDUFB6
|
[NCBI]
|
1.08512e-05
|
|
|
HES6
|
[NCBI]
|
1.08512e-05
|
|
|
slu7, s. cerevisiae, homolog of
|
[NCBI]
|
1.08512e-05
|
|
|
NUDT1
|
[NCBI]
|
1.08512e-05
|
|
|
IHPK2
|
[NCBI]
|
1.08512e-05
|
|
|
NELF
|
[NCBI]
|
1.08512e-05
|
|
|
KCNK9
|
[NCBI]
|
1.08512e-05
|
|
|
CLN5
|
[NCBI]
|
1.08512e-05
|
|
|
IFNA17
|
[NCBI]
|
1.08512e-05
|
|
|
SUOX
|
[NCBI]
|
1.08512e-05
|
|
|
MAPK12
|
[NCBI]
|
1.08512e-05
|
|
|
CTDP1
|
[NCBI]
|
1.08512e-05
|
|
|
SEPT4
|
[NCBI]
|
1.08512e-05
|
|
|
KRT13
|
[NCBI]
|
1.08512e-05
|
|
|
ALOXE3
|
[NCBI]
|
1.08512e-05
|
|
|
PLCD1
|
[NCBI]
|
1.08512e-05
|
|
|
SOX18
|
[NCBI]
|
1.08512e-05
|
|
|
MKNK1
|
[NCBI]
|
1.08512e-05
|
|
|
TCEB2
|
[NCBI]
|
1.08512e-05
|
|
|
FAM123B
|
[NCBI]
|
1.08512e-05
|
|
|
MAT2A
|
[NCBI]
|
1.08512e-05
|
|
|
AGPS
|
[NCBI]
|
1.08512e-05
|
|
|
MINK1
|
[NCBI]
|
1.08512e-05
|
|
|
EGR4
|
[NCBI]
|
1.08512e-05
|
|
|
PLEKHG4
|
[NCBI]
|
1.08512e-05
|
|
|
EBF2
|
[NCBI]
|
1.08512e-05
|
|
|
MTTG
|
[NCBI]
|
1.08512e-05
|
|
|
CDX1
|
[NCBI]
|
1.08512e-05
|
|
|
GPD1L
|
[NCBI]
|
1.08512e-05
|
|
|
GYS2
|
[NCBI]
|
1.08512e-05
|
|
|
MTTY
|
[NCBI]
|
1.08512e-05
|
|
|
FUT8
|
[NCBI]
|
1.08512e-05
|
|
|
UBE2C
|
[NCBI]
|
1.08512e-05
|
|
|
LFS1
|
[NCBI]
|
1.07985e-05
|
|
|
SCZD
|
[NCBI]
|
1.0767e-05
|
|
|
LPA
|
[NCBI]
|
1.06897e-05
|
|
|
MTCYB
|
[NCBI]
|
1.06897e-05
|
|
|
CHRNA4
|
[NCBI]
|
1.05785e-05
|
|
|
NEU1
|
[NCBI]
|
1.05785e-05
|
|
|
DHCR7
|
[NCBI]
|
1.05785e-05
|
|
|
NEB
|
[NCBI]
|
1.05785e-05
|
|
|
COMP
|
[NCBI]
|
1.05173e-05
|
|
|
ADHD
|
[NCBI]
|
1.02037e-05
|
|
|
TNXB
|
[NCBI]
|
1.01054e-05
|
|
|
EIF4G1
|
[NCBI]
|
1.01054e-05
|
|
|
DSP
|
[NCBI]
|
1.01054e-05
|
|
|
KAL1
|
[NCBI]
|
1.01028e-05
|
|
|
tyrosinemia, type i
|
[NCBI]
|
1.01028e-05
|
|
|
APC
|
[NCBI]
|
1.00923e-05
|
|
|
ACCPN
|
[NCBI]
|
1.00521e-05
|
|
|
EDM1
|
[NCBI]
|
1.00521e-05
|
|
|
monilethrix
|
[NCBI]
|
1.00521e-05
|
|
|
BMND1
|
[NCBI]
|
1.00521e-05
|
|
|
ED2
|
[NCBI]
|
1.00521e-05
|
|
|
OPD1
|
[NCBI]
|
1.00521e-05
|
|
|
galactose epimerase deficiency
|
[NCBI]
|
1.00521e-05
|
|
|
CMD3B
|
[NCBI]
|
1.00521e-05
|
|
|
crouzon syndrome
|
[NCBI]
|
1.00521e-05
|
|
|
epidermolysis bullosa simplex and limb-girdle muscular dystrophy
|
[NCBI]
|
1.00521e-05
|
|
|
cutis laxa, autosomal recessive, type ii
|
[NCBI]
|
1.00521e-05
|
|
|
septooptic dysplasia
|
[NCBI]
|
1.00521e-05
|
|
|
d-bifunctional protein deficiency
|
[NCBI]
|
1.00521e-05
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
9.82248e-06
|
|
|
ALPS
|
[NCBI]
|
9.77462e-06
|
|
|
FA
|
[NCBI]
|
9.76595e-06
|
|
|
MLH1
|
[NCBI]
|
9.7614e-06
|
|
|
DBH
|
[NCBI]
|
9.65937e-06
|
|
|
SLC5A5
|
[NCBI]
|
9.65937e-06
|
|
|
DKC1
|
[NCBI]
|
9.65937e-06
|
|
|
KRT1
|
[NCBI]
|
9.65937e-06
|
|
|
PDGFRA
|
[NCBI]
|
9.65937e-06
|
|
|
F12
|
[NCBI]
|
9.65937e-06
|
|
|
PDE6A
|
[NCBI]
|
9.45584e-06
|
|
|
CTPS
|
[NCBI]
|
9.45584e-06
|
|
|
PRKCSH
|
[NCBI]
|
9.45584e-06
|
|
|
IKZF3
|
[NCBI]
|
9.45584e-06
|
|
|
CLCNKA
|
[NCBI]
|
9.45584e-06
|
|
|
DYRK1B
|
[NCBI]
|
9.45584e-06
|
|
|
HYAL1
|
[NCBI]
|
9.45584e-06
|
|
|
PMP2
|
[NCBI]
|
9.45584e-06
|
|
|
CCM2
|
[NCBI]
|
9.45584e-06
|
|
|
PPP2R1B
|
[NCBI]
|
9.45584e-06
|
|
|
TGFA
|
[NCBI]
|
9.45584e-06
|
|
|
TCEB1
|
[NCBI]
|
9.45584e-06
|
|
|
PIK3CD
|
[NCBI]
|
9.45584e-06
|
|
|
PHF8
|
[NCBI]
|
9.45584e-06
|
|
|
IHPK1
|
[NCBI]
|
9.45584e-06
|
|
|
NDUFV1
|
[NCBI]
|
9.45584e-06
|
|
|
CTRC
|
[NCBI]
|
9.45584e-06
|
|
|
CD84
|
[NCBI]
|
9.45584e-06
|
|
|
TCEB3
|
[NCBI]
|
9.45584e-06
|
|
|
COQ2
|
[NCBI]
|
9.45584e-06
|
|
|
RHEB2
|
[NCBI]
|
9.45584e-06
|
|
|
PHF6
|
[NCBI]
|
9.45584e-06
|
|
|
EVC
|
[NCBI]
|
9.45584e-06
|
|
|
LRRFIP1
|
[NCBI]
|
9.45584e-06
|
|
|
PRDM2
|
[NCBI]
|
9.45584e-06
|
|
|
MANBA
|
[NCBI]
|
9.45584e-06
|
|
|
CSNK1E
|
[NCBI]
|
9.45584e-06
|
|
|
ALG12
|
[NCBI]
|
9.45584e-06
|
|
|
GLRB
|
[NCBI]
|
9.45584e-06
|
|
|
FKBP4
|
[NCBI]
|
9.45584e-06
|
|
|
TAS1R2
|
[NCBI]
|
9.45584e-06
|
|
|
MASP2
|
[NCBI]
|
9.45584e-06
|
|
|
EIF4B
|
[NCBI]
|
9.45584e-06
|
|
|
ERMAP
|
[NCBI]
|
9.45584e-06
|
|
|
multiple coagulation factor deficiency protein 2
|
[NCBI]
|
9.45584e-06
|
|
|
SLC25A32
|
[NCBI]
|
9.45584e-06
|
|
|
HTRA2
|
[NCBI]
|
9.45584e-06
|
|
|
KRTHB1
|
[NCBI]
|
9.45584e-06
|
|
|
OSBPL3
|
[NCBI]
|
9.45584e-06
|
|
|
VPS33B
|
[NCBI]
|
9.45584e-06
|
|
|
GABRA6
|
[NCBI]
|
9.45584e-06
|
|
|
NCR3
|
[NCBI]
|
9.45584e-06
|
|
|
SH3TC2
|
[NCBI]
|
9.45584e-06
|
|
|
MIB2
|
[NCBI]
|
9.45584e-06
|
|
|
SDCBP
|
[NCBI]
|
9.45584e-06
|
|
|
SLC25A12
|
[NCBI]
|
9.45584e-06
|
|
|
CLN6
|
[NCBI]
|
9.45584e-06
|
|
|
ELAVL1
|
[NCBI]
|
9.45584e-06
|
|
|
EFEMP1
|
[NCBI]
|
9.45584e-06
|
|
|
AMHR2
|
[NCBI]
|
9.45584e-06
|
|
|
suppressor of t-cell receptor signaling 1
|
[NCBI]
|
9.45584e-06
|
|
|
CA8
|
[NCBI]
|
9.45584e-06
|
|
|
KCNB1
|
[NCBI]
|
9.45584e-06
|
|
|
PIP5K1B
|
[NCBI]
|
9.45584e-06
|
|
|
GFRA3
|
[NCBI]
|
9.45584e-06
|
|
|
MAF1
|
[NCBI]
|
9.45584e-06
|
|
|
NINJ1
|
[NCBI]
|
9.45584e-06
|
|
|
FMR1
|
[NCBI]
|
9.37076e-06
|
|
|
UBE3A
|
[NCBI]
|
9.23797e-06
|
|
|
NKX2-1
|
[NCBI]
|
9.23797e-06
|
|
|
AACT
|
[NCBI]
|
9.23797e-06
|
|
|
TCOF1
|
[NCBI]
|
9.23797e-06
|
|
|
GJB3
|
[NCBI]
|
9.23797e-06
|
|
|
LAMB3
|
[NCBI]
|
9.23797e-06
|
|
|
GPI
|
[NCBI]
|
9.12512e-06
|
|
|
SCA1
|
[NCBI]
|
9.10225e-06
|
|
|
POAG
|
[NCBI]
|
9.03749e-06
|
|
|
FOP
|
[NCBI]
|
9.03749e-06
|
|
|
AKT1
|
[NCBI]
|
9.02983e-06
|
|
|
diabetes mellitus, insulin-resistant, with acanthosis nigricans
|
[NCBI]
|
8.99192e-06
|
|
|
CDS
|
[NCBI]
|
8.99192e-06
|
|
|
NFNS
|
[NCBI]
|
8.99192e-06
|
|
|
coenzyme q10 deficiency
|
[NCBI]
|
8.99192e-06
|
|
|
gm1-gangliosidosis, type iii
|
[NCBI]
|
8.99192e-06
|
|
|
erythrocytosis, familial, 2
|
[NCBI]
|
8.99192e-06
|
|
|
LQT3
|
[NCBI]
|
8.99192e-06
|
|
|
JME
|
[NCBI]
|
8.99192e-06
|
|
|
HFTC
|
[NCBI]
|
8.99192e-06
|
|
|
cerebrotendinous xanthomatosis
|
[NCBI]
|
8.99192e-06
|
|
|
ARVD1
|
[NCBI]
|
8.99192e-06
|
|
|
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1
|
[NCBI]
|
8.99192e-06
|
|
|
asplenia with cardiovascular anomalies
|
[NCBI]
|
8.99192e-06
|
|
|
HSCR2
|
[NCBI]
|
8.99192e-06
|
|
|
FAAH
|
[NCBI]
|
8.88134e-06
|
|
|
IRF1
|
[NCBI]
|
8.83913e-06
|
|
|
PINK1
|
[NCBI]
|
8.83913e-06
|
|
|
LHB
|
[NCBI]
|
8.83913e-06
|
|
|
NP
|
[NCBI]
|
8.78062e-06
|
|
|
BMD
|
[NCBI]
|
8.50514e-06
|
|
|
RSTS
|
[NCBI]
|
8.50514e-06
|
|
|
KLF6
|
[NCBI]
|
8.46101e-06
|
|
|
CENPB
|
[NCBI]
|
8.36579e-06
|
|
|
MYL3
|
[NCBI]
|
8.36579e-06
|
|
|
humanin
|
[NCBI]
|
8.36579e-06
|
|
|
GABRA2
|
[NCBI]
|
8.36579e-06
|
|
|
FRS2
|
[NCBI]
|
8.36579e-06
|
|
|
NDST1
|
[NCBI]
|
8.36579e-06
|
|
|
STUB1
|
[NCBI]
|
8.36579e-06
|
|
|
PCSK7
|
[NCBI]
|
8.36579e-06
|
|
|
SGTA
|
[NCBI]
|
8.36579e-06
|
|
|
SRG1
|
[NCBI]
|
8.36579e-06
|
|
|
TAS1R1
|
[NCBI]
|
8.36579e-06
|
|
|
MYO10
|
[NCBI]
|
8.36579e-06
|
|
|
MAP3K10
|
[NCBI]
|
8.36579e-06
|
|
|
NIPA1
|
[NCBI]
|
8.36579e-06
|
|
|
KCNAB2
|
[NCBI]
|
8.36579e-06
|
|
|
bsnd gene
|
[NCBI]
|
8.36579e-06
|
|
|
EGLN1
|
[NCBI]
|
8.36579e-06
|
|
|
PSCD1
|
[NCBI]
|
8.36579e-06
|
|
|
TWIST2
|
[NCBI]
|
8.36579e-06
|
|
|
NLGN4
|
[NCBI]
|
8.36579e-06
|
|
|
KIF5A
|
[NCBI]
|
8.36579e-06
|
|
|
GGTA1
|
[NCBI]
|
8.36579e-06
|
|
|
EHD1
|
[NCBI]
|
8.36579e-06
|
|
|
NMBR
|
[NCBI]
|
8.36579e-06
|
|
|
CFC1
|
[NCBI]
|
8.36579e-06
|
|
|
SLC4A11
|
[NCBI]
|
8.36579e-06
|
|
|
RFXANK
|
[NCBI]
|
8.36579e-06
|
|
|
COX10
|
[NCBI]
|
8.36579e-06
|
|
|
DDX20
|
[NCBI]
|
8.36579e-06
|
|
|
MYL2
|
[NCBI]
|
8.36579e-06
|
|
|
MTTH
|
[NCBI]
|
8.36579e-06
|
|
|
ARRB1
|
[NCBI]
|
8.36579e-06
|
|
|
3-@beta-hydroxysteroid dehydrogenase/delta-isomerase, type i
|
[NCBI]
|
8.36579e-06
|
|
|
SLC35C1
|
[NCBI]
|
8.36579e-06
|
|
|
ALOX12B
|
[NCBI]
|
8.36579e-06
|
|
|
NDUFS1
|
[NCBI]
|
8.36579e-06
|
|
|
CRMP1
|
[NCBI]
|
8.36579e-06
|
|
|
VBP1
|
[NCBI]
|
8.36579e-06
|
|
|
ZFPM1
|
[NCBI]
|
8.36579e-06
|
|
|
FBXL3
|
[NCBI]
|
8.36579e-06
|
|
|
PSAP
|
[NCBI]
|
8.30293e-06
|
|
|
lynch syndrome i
|
[NCBI]
|
8.13131e-06
|
|
|
SDS
|
[NCBI]
|
8.13131e-06
|
|
|
SCN1A
|
[NCBI]
|
8.10197e-06
|
|
|
LYZ
|
[NCBI]
|
8.10197e-06
|
|
|
CACNA1C
|
[NCBI]
|
8.10197e-06
|
|
|
GALT
|
[NCBI]
|
8.07394e-06
|
|
|
hypophosphatasia, adult type
|
[NCBI]
|
8.0421e-06
|
|
|
tibial muscular dystrophy, tardive
|
[NCBI]
|
8.0421e-06
|
|
|
gilbert syndrome
|
[NCBI]
|
8.0421e-06
|
|
|
LMS
|
[NCBI]
|
8.0421e-06
|
|
|
CDG2C
|
[NCBI]
|
8.0421e-06
|
|
|
LGMD2B
|
[NCBI]
|
8.0421e-06
|
|
|
UMS
|
[NCBI]
|
8.0421e-06
|
|
|
alpha-thalassemia/mental retardation syndrome, deletion-type
|
[NCBI]
|
8.0421e-06
|
|
|
PALS
|
[NCBI]
|
8.0421e-06
|
|
|
succinic semialdehyde dehydrogenase deficiency
|
[NCBI]
|
8.0421e-06
|
|
|
glutaric acidemia i
|
[NCBI]
|
8.0421e-06
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 1
|
[NCBI]
|
8.0421e-06
|
|
|
MTS
|
[NCBI]
|
8.0421e-06
|
|
|
CHNG1
|
[NCBI]
|
8.0421e-06
|
|
|
LPL
|
[NCBI]
|
7.98644e-06
|
|
|
PEDF
|
[NCBI]
|
7.85494e-06
|
|
|
TYMS
|
[NCBI]
|
7.80033e-06
|
|
|
CHM
|
[NCBI]
|
7.76057e-06
|
|
|
COL4A3
|
[NCBI]
|
7.76057e-06
|
|
|
EYA1
|
[NCBI]
|
7.76057e-06
|
|
|
BL
|
[NCBI]
|
7.69534e-06
|
|
|
MB
|
[NCBI]
|
7.69262e-06
|
|
|
ZS
|
[NCBI]
|
7.51862e-06
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
7.51447e-06
|
|
|
OSM
|
[NCBI]
|
7.51052e-06
|
|
|
MYH10
|
[NCBI]
|
7.47748e-06
|
|
|
TPM2
|
[NCBI]
|
7.47748e-06
|
|
|
MIRN15A
|
[NCBI]
|
7.47748e-06
|
|
|
SLC25A5
|
[NCBI]
|
7.47748e-06
|
|
|
RYK
|
[NCBI]
|
7.47748e-06
|
|
|
PHKB
|
[NCBI]
|
7.47748e-06
|
|
|
TXNRD2
|
[NCBI]
|
7.47748e-06
|
|
|
CHRNB1
|
[NCBI]
|
7.47748e-06
|
|
|
TTID
|
[NCBI]
|
7.47748e-06
|
|
|
TRPV6
|
[NCBI]
|
7.47748e-06
|
|
|
CACNA2D1
|
[NCBI]
|
7.47748e-06
|
|
|
ACTN4
|
[NCBI]
|
7.47748e-06
|
|
|
ACTR2
|
[NCBI]
|
7.47748e-06
|
|
|
PLCE1
|
[NCBI]
|
7.47748e-06
|
|
|
UBE2D1
|
[NCBI]
|
7.47748e-06
|
|
|
NSDHL
|
[NCBI]
|
7.47748e-06
|
|
|
PTPN12
|
[NCBI]
|
7.47748e-06
|
|
|
ADCY3
|
[NCBI]
|
7.47748e-06
|
|
|
HSPB8
|
[NCBI]
|
7.47748e-06
|
|
|
CCNT1
|
[NCBI]
|
7.47748e-06
|
|
|
MADD
|
[NCBI]
|
7.47748e-06
|
|
|
C1QB
|
[NCBI]
|
7.47748e-06
|
|
|
ALDH4A1
|
[NCBI]
|
7.47748e-06
|
|
|
TRPV5
|
[NCBI]
|
7.47748e-06
|
|
|
NOXO1
|
[NCBI]
|
7.47748e-06
|
|
|
SLURP1
|
[NCBI]
|
7.47748e-06
|
|
|
SGNE1
|
[NCBI]
|
7.47748e-06
|
|
|
IL5RA
|
[NCBI]
|
7.47748e-06
|
|
|
QKI
|
[NCBI]
|
7.47748e-06
|
|
|
CDKN2C
|
[NCBI]
|
7.47748e-06
|
|
|
CNGA1
|
[NCBI]
|
7.47748e-06
|
|
|
MGEA5
|
[NCBI]
|
7.47748e-06
|
|
|
NDUFS8
|
[NCBI]
|
7.47748e-06
|
|
|
KCNE3
|
[NCBI]
|
7.47748e-06
|
|
|
WNT2
|
[NCBI]
|
7.47748e-06
|
|
|
ALDH5A1
|
[NCBI]
|
7.47748e-06
|
|
|
GCLC
|
[NCBI]
|
7.47748e-06
|
|
|
PTPNS1
|
[NCBI]
|
7.47748e-06
|
|
|
EIF4G2
|
[NCBI]
|
7.47748e-06
|
|
|
CLN8
|
[NCBI]
|
7.47748e-06
|
|
|
AICDA
|
[NCBI]
|
7.43553e-06
|
|
|
DYT1
|
[NCBI]
|
7.43553e-06
|
|
|
LBR
|
[NCBI]
|
7.42352e-06
|
|
|
CCD
|
[NCBI]
|
7.41428e-06
|
|
|
DCC
|
[NCBI]
|
7.21818e-06
|
|
|
lecithin:cholesterol acyltransferase deficiency
|
[NCBI]
|
7.18793e-06
|
|
|
coumarin resistance
|
[NCBI]
|
7.18793e-06
|
|
|
exostoses, multiple, type ii
|
[NCBI]
|
7.18793e-06
|
|
|
PPAC
|
[NCBI]
|
7.18793e-06
|
|
|
IPEX
|
[NCBI]
|
7.18793e-06
|
|
|
hurler-scheie syndrome
|
[NCBI]
|
7.18793e-06
|
|
|
IVA
|
[NCBI]
|
7.18793e-06
|
|
|
IHH
|
[NCBI]
|
7.15917e-06
|
|
|
TPO
|
[NCBI]
|
7.1571e-06
|
|
|
FABP2
|
[NCBI]
|
7.12569e-06
|
|
|
SLC25A4
|
[NCBI]
|
7.12569e-06
|
|
|
IKBKB
|
[NCBI]
|
7.12569e-06
|
|
|
PRSS1
|
[NCBI]
|
7.12569e-06
|
|
|
ABL
|
[NCBI]
|
7.05381e-06
|
|
|
RPGR
|
[NCBI]
|
7.01825e-06
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
7.01068e-06
|
|
|
IAPP
|
[NCBI]
|
6.84499e-06
|
|
|
RYR2
|
[NCBI]
|
6.83003e-06
|
|
|
HNF1A
|
[NCBI]
|
6.79011e-06
|
|
|
RPL4
|
[NCBI]
|
6.73254e-06
|
|
|
NDUFS4
|
[NCBI]
|
6.73254e-06
|
|
|
SIL1
|
[NCBI]
|
6.73254e-06
|
|
|
HADHB
|
[NCBI]
|
6.73254e-06
|
|
|
FKBP1B
|
[NCBI]
|
6.73254e-06
|
|
|
PAI2
|
[NCBI]
|
6.73254e-06
|
|
|
TRPM7
|
[NCBI]
|
6.73254e-06
|
|
|
PEX6
|
[NCBI]
|
6.73254e-06
|
|
|
COL9A3
|
[NCBI]
|
6.73254e-06
|
|
|
UNC13B
|
[NCBI]
|
6.73254e-06
|
|
|
HSD17B1
|
[NCBI]
|
6.73254e-06
|
|
|
SEPN1
|
[NCBI]
|
6.73254e-06
|
|
|
PICALM
|
[NCBI]
|
6.73254e-06
|
|
|
CLDN14
|
[NCBI]
|
6.73254e-06
|
|
|
MOCS2
|
[NCBI]
|
6.73254e-06
|
|
|
FSCN2
|
[NCBI]
|
6.73254e-06
|
|
|
AKAP9
|
[NCBI]
|
6.73254e-06
|
|
|
RAB3A
|
[NCBI]
|
6.73254e-06
|
|
|
CYP4A11
|
[NCBI]
|
6.73254e-06
|
|
|
EVC2
|
[NCBI]
|
6.73254e-06
|
|
|
AURKC
|
[NCBI]
|
6.73254e-06
|
|
|
DNM1
|
[NCBI]
|
6.73254e-06
|
|
|
ADARB1
|
[NCBI]
|
6.73254e-06
|
|
|
SNCB
|
[NCBI]
|
6.73254e-06
|
|
|
USP9Y
|
[NCBI]
|
6.73254e-06
|
|
|
GCGR
|
[NCBI]
|
6.73254e-06
|
|
|
BLVRA
|
[NCBI]
|
6.73254e-06
|
|
|
MAP3K14
|
[NCBI]
|
6.73254e-06
|
|
|
BMP5
|
[NCBI]
|
6.73254e-06
|
|
|
CLCN2
|
[NCBI]
|
6.73254e-06
|
|
|
FUT6
|
[NCBI]
|
6.73254e-06
|
|
|
MIRN1-1
|
[NCBI]
|
6.73254e-06
|
|
|
NOVA1
|
[NCBI]
|
6.73254e-06
|
|
|
OGFR
|
[NCBI]
|
6.73254e-06
|
|
|
GABRD
|
[NCBI]
|
6.73254e-06
|
|
|
NT5C3
|
[NCBI]
|
6.73254e-06
|
|
|
EIF6
|
[NCBI]
|
6.73254e-06
|
|
|
SLC7A7
|
[NCBI]
|
6.73254e-06
|
|
|
SLC25A13
|
[NCBI]
|
6.73254e-06
|
|
|
SDHA
|
[NCBI]
|
6.73254e-06
|
|
|
INADL
|
[NCBI]
|
6.73254e-06
|
|
|
BCS1L
|
[NCBI]
|
6.73254e-06
|
|
|
PGK1
|
[NCBI]
|
6.63387e-06
|
|
|
ALGS1
|
[NCBI]
|
6.61484e-06
|
|
|
NPC1
|
[NCBI]
|
6.54761e-06
|
|
|
CDK9
|
[NCBI]
|
6.54761e-06
|
|
|
KCNJ11
|
[NCBI]
|
6.54761e-06
|
|
|
IRS2
|
[NCBI]
|
6.54761e-06
|
|
|
CST3
|
[NCBI]
|
6.54761e-06
|
|
|
MAS
|
[NCBI]
|
6.51349e-06
|
|
|
NOS3
|
[NCBI]
|
6.44908e-06
|
|
|
MKKS
|
[NCBI]
|
6.41741e-06
|
|
|
refsum disease
|
[NCBI]
|
6.41741e-06
|
|
|
RSMD1
|
[NCBI]
|
6.41741e-06
|
|
|
DHRD
|
[NCBI]
|
6.41741e-06
|
|
|
blood group, p system
|
[NCBI]
|
6.41741e-06
|
|
|
SPCH1
|
[NCBI]
|
6.41741e-06
|
|
|
OPTB3
|
[NCBI]
|
6.41741e-06
|
|
|
periodontitis, aggressive, 1
|
[NCBI]
|
6.41741e-06
|
|
|
FXTAS
|
[NCBI]
|
6.41741e-06
|
|
|
neural tube defects, folate-sensitive
|
[NCBI]
|
6.41741e-06
|
|
|
dopamine beta-hydroxylase deficiency, congenital
|
[NCBI]
|
6.41741e-06
|
|
|
CIPA
|
[NCBI]
|
6.41741e-06
|
|
|
PTPN11
|
[NCBI]
|
6.2776e-06
|
|
|
ALPL
|
[NCBI]
|
6.2776e-06
|
|
|
ABCG2
|
[NCBI]
|
6.25267e-06
|
|
|
CDK5
|
[NCBI]
|
6.20749e-06
|
|
|
SMAX1
|
[NCBI]
|
6.18291e-06
|
|
|
FKBP1A
|
[NCBI]
|
6.09482e-06
|
|
|
PITPN
|
[NCBI]
|
6.09482e-06
|
|
|
DYNC1H1
|
[NCBI]
|
6.09482e-06
|
|
|
MIRN16-1
|
[NCBI]
|
6.09482e-06
|
|
|
CRLF1
|
[NCBI]
|
6.09482e-06
|
|
|
TDGF1
|
[NCBI]
|
6.09482e-06
|
|
|
SOD3
|
[NCBI]
|
6.09482e-06
|
|
|
BCKDHB
|
[NCBI]
|
6.09482e-06
|
|
|
MKKS
|
[NCBI]
|
6.09482e-06
|
|
|
HOMER1
|
[NCBI]
|
6.09482e-06
|
|
|
CLCNKB
|
[NCBI]
|
6.09482e-06
|
|
|
ERCC4
|
[NCBI]
|
6.09482e-06
|
|
|
GRHPR
|
[NCBI]
|
6.09482e-06
|
|
|
MYLK
|
[NCBI]
|
6.09482e-06
|
|
|
CHRND
|
[NCBI]
|
6.09482e-06
|
|
|
TCF12
|
[NCBI]
|
6.09482e-06
|
|
|
FADD
|
[NCBI]
|
6.09482e-06
|
|
|
CCKBR
|
[NCBI]
|
6.09482e-06
|
|
|
KRT12
|
[NCBI]
|
6.09482e-06
|
|
|
VDAC1
|
[NCBI]
|
6.09482e-06
|
|
|
GRIK1
|
[NCBI]
|
6.09482e-06
|
|
|
GPD2
|
[NCBI]
|
6.09482e-06
|
|
|
ROCK1
|
[NCBI]
|
6.09482e-06
|
|
|
HTR2C
|
[NCBI]
|
6.09482e-06
|
|
|
TEK
|
[NCBI]
|
6.09482e-06
|
|
|
hemojuvelin
|
[NCBI]
|
6.09482e-06
|
|
|
F2RL3
|
[NCBI]
|
6.09482e-06
|
|
|
ACTN3
|
[NCBI]
|
6.09482e-06
|
|
|
SLC34A1
|
[NCBI]
|
6.09482e-06
|
|
|
DNASE1
|
[NCBI]
|
6.09482e-06
|
|
|
GNAI2
|
[NCBI]
|
6.09482e-06
|
|
|
MAOB
|
[NCBI]
|
6.01922e-06
|
|
|
TERC
|
[NCBI]
|
6.01922e-06
|
|
|
DYSF
|
[NCBI]
|
6.01922e-06
|
|
|
KITLG
|
[NCBI]
|
5.95639e-06
|
|
|
CFI
|
[NCBI]
|
5.77178e-06
|
|
|
JAK3
|
[NCBI]
|
5.75569e-06
|
|
|
FTD
|
[NCBI]
|
5.72662e-06
|
|
|
glycogen storage disease iv
|
[NCBI]
|
5.72069e-06
|
|
|
MNS
|
[NCBI]
|
5.72069e-06
|
|
|
FBS
|
[NCBI]
|
5.72069e-06
|
|
|
ABS
|
[NCBI]
|
5.72069e-06
|
|
|
glucose transport defect, blood-brain barrier
|
[NCBI]
|
5.72069e-06
|
|
|
leopard syndrome 1
|
[NCBI]
|
5.72069e-06
|
|
|
FHM2
|
[NCBI]
|
5.72069e-06
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
5.72069e-06
|
|
|
bladder cancer
|
[NCBI]
|
5.72069e-06
|
|
|
APOE
|
[NCBI]
|
5.65707e-06
|
|
|
KCNJ6
|
[NCBI]
|
5.5403e-06
|
|
|
RP1
|
[NCBI]
|
5.5403e-06
|
|
|
PLCB3
|
[NCBI]
|
5.5403e-06
|
|
|
SETX
|
[NCBI]
|
5.5403e-06
|
|
|
HTN3
|
[NCBI]
|
5.5403e-06
|
|
|
EDAR
|
[NCBI]
|
5.5403e-06
|
|
|
flaujeac factor deficiency
|
[NCBI]
|
5.5403e-06
|
|
|
SCO2
|
[NCBI]
|
5.5403e-06
|
|
|
PEX12
|
[NCBI]
|
5.5403e-06
|
|
|
SOX4
|
[NCBI]
|
5.5403e-06
|
|
|
SLC19A2
|
[NCBI]
|
5.5403e-06
|
|
|
LITAF
|
[NCBI]
|
5.5403e-06
|
|
|
MGAT1
|
[NCBI]
|
5.5403e-06
|
|
|
ICSBP1
|
[NCBI]
|
5.5403e-06
|
|
|
AMT
|
[NCBI]
|
5.5403e-06
|
|
|
MAPK6
|
[NCBI]
|
5.5403e-06
|
|
|
RAC2
|
[NCBI]
|
5.5403e-06
|
|
|
GBE1
|
[NCBI]
|
5.5403e-06
|
|
|
TRPS1
|
[NCBI]
|
5.5403e-06
|
|
|
CD28
|
[NCBI]
|
5.5403e-06
|
|
|
APOA5
|
[NCBI]
|
5.5403e-06
|
|
|
A4GALT
|
[NCBI]
|
5.5403e-06
|
|
|
OXTR
|
[NCBI]
|
5.5403e-06
|
|
|
IRAK4
|
[NCBI]
|
5.5403e-06
|
|
|
TUB
|
[NCBI]
|
5.5403e-06
|
|
|
CNGB3
|
[NCBI]
|
5.5403e-06
|
|
|
TOP1
|
[NCBI]
|
5.5403e-06
|
|
|
MBD4
|
[NCBI]
|
5.5403e-06
|
|
|
SREBF2
|
[NCBI]
|
5.5403e-06
|
|
|
PABPN1
|
[NCBI]
|
5.5403e-06
|
|
|
GRID2
|
[NCBI]
|
5.5403e-06
|
|
|
FMO3
|
[NCBI]
|
5.53465e-06
|
|
|
SPG4
|
[NCBI]
|
5.53465e-06
|
|
|
IKBKG
|
[NCBI]
|
5.53465e-06
|
|
|
KCNH2
|
[NCBI]
|
5.46612e-06
|
|
|
galactosemia
|
[NCBI]
|
5.41867e-06
|
|
|
PLTP
|
[NCBI]
|
5.37349e-06
|
|
|
EPHX1
|
[NCBI]
|
5.30725e-06
|
|
|
MTCO2
|
[NCBI]
|
5.30725e-06
|
|
|
OA1
|
[NCBI]
|
5.30725e-06
|
|
|
STAR
|
[NCBI]
|
5.25327e-06
|
|
|
JMML
|
[NCBI]
|
5.2499e-06
|
|
|
wilson disease
|
[NCBI]
|
5.2499e-06
|
|
|
EIG
|
[NCBI]
|
5.24671e-06
|
|
|
BCHE
|
[NCBI]
|
5.20043e-06
|
|
|
BCR
|
[NCBI]
|
5.16378e-06
|
|
|
MCP
|
[NCBI]
|
5.15842e-06
|
|
|
CDK4
|
[NCBI]
|
5.10238e-06
|
|
|
HNA
|
[NCBI]
|
5.08956e-06
|
|
|
TTDP
|
[NCBI]
|
5.08956e-06
|
|
|
BFLS
|
[NCBI]
|
5.08956e-06
|
|
|
PCLD
|
[NCBI]
|
5.08956e-06
|
|
|
IBM2
|
[NCBI]
|
5.08956e-06
|
|
|
osteogenesis imperfecta, type iv
|
[NCBI]
|
5.08956e-06
|
|
|
EBN1
|
[NCBI]
|
5.08956e-06
|
|
|
pancreatic carcinoma
|
[NCBI]
|
5.08956e-06
|
|
|
CBAVD
|
[NCBI]
|
5.08956e-06
|
|
|
GUSB
|
[NCBI]
|
5.07824e-06
|
|
|
NF2
|
[NCBI]
|
5.05735e-06
|
|
|
SLC2A3
|
[NCBI]
|
5.05226e-06
|
|
|
FACL4
|
[NCBI]
|
5.05226e-06
|
|
|
INSIG2
|
[NCBI]
|
5.05226e-06
|
|
|
HOXA1
|
[NCBI]
|
5.05226e-06
|
|
|
NAGS
|
[NCBI]
|
5.05226e-06
|
|
|
SORD
|
[NCBI]
|
5.05226e-06
|
|
|
LIM2
|
[NCBI]
|
5.05226e-06
|
|
|
TIMP2
|
[NCBI]
|
5.05226e-06
|
|
|
FGD1
|
[NCBI]
|
5.05226e-06
|
|
|
HOXA13
|
[NCBI]
|
5.05226e-06
|
|
|
PKP1
|
[NCBI]
|
5.05226e-06
|
|
|
PLEC1
|
[NCBI]
|
5.05226e-06
|
|
|
WASF1
|
[NCBI]
|
5.05226e-06
|
|
|
PPP2R4
|
[NCBI]
|
5.05226e-06
|
|
|
TAS1R3
|
[NCBI]
|
5.05226e-06
|
|
|
MFNG
|
[NCBI]
|
5.05226e-06
|
|
|
KRT16
|
[NCBI]
|
5.05226e-06
|
|
|
AAAS
|
[NCBI]
|
5.05226e-06
|
|
|
INSIG1
|
[NCBI]
|
5.05226e-06
|
|
|
GATA2
|
[NCBI]
|
5.05226e-06
|
|
|
HADH
|
[NCBI]
|
5.05226e-06
|
|
|
RBBP8
|
[NCBI]
|
5.05226e-06
|
|
|
POMGNT1
|
[NCBI]
|
5.05226e-06
|
|
|
SLC2A4
|
[NCBI]
|
5.01617e-06
|
|
|
ANG
|
[NCBI]
|
4.98188e-06
|
|
|
FGG
|
[NCBI]
|
4.87952e-06
|
|
|
ATP7A
|
[NCBI]
|
4.87952e-06
|
|
|
SI
|
[NCBI]
|
4.84909e-06
|
|
|
PIGR
|
[NCBI]
|
4.84909e-06
|
|
|
AN2
|
[NCBI]
|
4.71343e-06
|
|
|
FANCC
|
[NCBI]
|
4.67826e-06
|
|
|
PDE6B
|
[NCBI]
|
4.67826e-06
|
|
|
CHEK2
|
[NCBI]
|
4.67826e-06
|
|
|
TPI1
|
[NCBI]
|
4.67826e-06
|
|
|
RECQL2
|
[NCBI]
|
4.67826e-06
|
|
|
CRHR2
|
[NCBI]
|
4.61856e-06
|
|
|
LTK
|
[NCBI]
|
4.61856e-06
|
|
|
SAG
|
[NCBI]
|
4.61856e-06
|
|
|
RDH5
|
[NCBI]
|
4.61856e-06
|
|
|
DAPK1
|
[NCBI]
|
4.61856e-06
|
|
|
ZIC3
|
[NCBI]
|
4.61856e-06
|
|
|
GLUL
|
[NCBI]
|
4.61856e-06
|
|
|
IVL
|
[NCBI]
|
4.61856e-06
|
|
|
SCN8A
|
[NCBI]
|
4.61856e-06
|
|
|
CILP
|
[NCBI]
|
4.61856e-06
|
|
|
NOX1
|
[NCBI]
|
4.61856e-06
|
|
|
FYB
|
[NCBI]
|
4.61856e-06
|
|
|
PFN1
|
[NCBI]
|
4.61856e-06
|
|
|
ITPR1
|
[NCBI]
|
4.61856e-06
|
|
|
MSH3
|
[NCBI]
|
4.61856e-06
|
|
|
EIF2AK3
|
[NCBI]
|
4.61856e-06
|
|
|
DGUOK
|
[NCBI]
|
4.61856e-06
|
|
|
CD55
|
[NCBI]
|
4.61856e-06
|
|
|
UBQLN1
|
[NCBI]
|
4.61856e-06
|
|
|
ERAF
|
[NCBI]
|
4.61856e-06
|
|
|
PEA15
|
[NCBI]
|
4.61856e-06
|
|
|
KCNQ4
|
[NCBI]
|
4.61856e-06
|
|
|
SMARCA4
|
[NCBI]
|
4.61856e-06
|
|
|
MS4A2
|
[NCBI]
|
4.61856e-06
|
|
|
MERTK
|
[NCBI]
|
4.61856e-06
|
|
|
refsum disease, infantile form
|
[NCBI]
|
4.5171e-06
|
|
|
HEPOD
|
[NCBI]
|
4.5171e-06
|
|
|
AAA
|
[NCBI]
|
4.5171e-06
|
|
|
EL1
|
[NCBI]
|
4.5171e-06
|
|
|
PMC
|
[NCBI]
|
4.5171e-06
|
|
|
MSS
|
[NCBI]
|
4.5171e-06
|
|
|
DSG1
|
[NCBI]
|
4.48483e-06
|
|
|
PSORS1
|
[NCBI]
|
4.42371e-06
|
|
|
SMN2
|
[NCBI]
|
4.29885e-06
|
|
|
DES
|
[NCBI]
|
4.29885e-06
|
|
|
AGER
|
[NCBI]
|
4.25098e-06
|
|
|
BGLAP
|
[NCBI]
|
4.25098e-06
|
|
|
NSEP1
|
[NCBI]
|
4.2301e-06
|
|
|
KRT18
|
[NCBI]
|
4.2301e-06
|
|
|
PIN1
|
[NCBI]
|
4.2301e-06
|
|
|
ANXA2
|
[NCBI]
|
4.2301e-06
|
|
|
WWOX
|
[NCBI]
|
4.2301e-06
|
|
|
RMRP
|
[NCBI]
|
4.2301e-06
|
|
|
RUNX3
|
[NCBI]
|
4.2301e-06
|
|
|
NDRG1
|
[NCBI]
|
4.2301e-06
|
|
|
CLCN7
|
[NCBI]
|
4.2301e-06
|
|
|
ATP2A1
|
[NCBI]
|
4.2301e-06
|
|
|
LGI1
|
[NCBI]
|
4.2301e-06
|
|
|
RBPSUH
|
[NCBI]
|
4.2301e-06
|
|
|
OCRL
|
[NCBI]
|
4.2301e-06
|
|
|
DYRK1A
|
[NCBI]
|
4.2301e-06
|
|
|
COL6A3
|
[NCBI]
|
4.2301e-06
|
|
|
SIX3
|
[NCBI]
|
4.2301e-06
|
|
|
PRDX5
|
[NCBI]
|
4.2301e-06
|
|
|
EMX2
|
[NCBI]
|
4.2301e-06
|
|
|
ICAM5
|
[NCBI]
|
4.2301e-06
|
|
|
PON1
|
[NCBI]
|
4.18294e-06
|
|
|
PTEN
|
[NCBI]
|
4.15165e-06
|
|
|
HIF1A
|
[NCBI]
|
4.11995e-06
|
|
|
HBG1
|
[NCBI]
|
4.04718e-06
|
|
|
APOA1
|
[NCBI]
|
4.04718e-06
|
|
|
GLC3A
|
[NCBI]
|
3.99744e-06
|
|
|
EBR1
|
[NCBI]
|
3.99744e-06
|
|
|
CBX5
|
[NCBI]
|
3.98049e-06
|
|
|
FOLH1
|
[NCBI]
|
3.9478e-06
|
|
|
SFTPC
|
[NCBI]
|
3.8799e-06
|
|
|
TCIRG1
|
[NCBI]
|
3.8799e-06
|
|
|
CRYGA
|
[NCBI]
|
3.8799e-06
|
|
|
PXMP3
|
[NCBI]
|
3.8799e-06
|
|
|
ATP1A1
|
[NCBI]
|
3.8799e-06
|
|
|
ATXN2
|
[NCBI]
|
3.8799e-06
|
|
|
TRAPPC2
|
[NCBI]
|
3.8799e-06
|
|
|
FLNB
|
[NCBI]
|
3.8799e-06
|
|
|
GABRA1
|
[NCBI]
|
3.8799e-06
|
|
|
RAI1
|
[NCBI]
|
3.8799e-06
|
|
|
CCS
|
[NCBI]
|
3.8799e-06
|
|
|
MYF6
|
[NCBI]
|
3.8799e-06
|
|
|
BLMH
|
[NCBI]
|
3.8799e-06
|
|
|
CALCR
|
[NCBI]
|
3.8799e-06
|
|
|
KCNJ1
|
[NCBI]
|
3.8799e-06
|
|
|
LEP
|
[NCBI]
|
3.82269e-06
|
|
|
DSTN
|
[NCBI]
|
3.78209e-06
|
|
|
GIST
|
[NCBI]
|
3.75173e-06
|
|
|
ENG
|
[NCBI]
|
3.62253e-06
|
|
|
SCA2
|
[NCBI]
|
3.5829e-06
|
|
|
TRPV1
|
[NCBI]
|
3.58038e-06
|
|
|
PCSK9
|
[NCBI]
|
3.56248e-06
|
|
|
FSHB
|
[NCBI]
|
3.56248e-06
|
|
|
BCKDHA
|
[NCBI]
|
3.56248e-06
|
|
|
SPAM1
|
[NCBI]
|
3.56248e-06
|
|
|
PRPH
|
[NCBI]
|
3.56248e-06
|
|
|
PDCD4
|
[NCBI]
|
3.56248e-06
|
|
|
MTMR2
|
[NCBI]
|
3.56248e-06
|
|
|
JUP
|
[NCBI]
|
3.56248e-06
|
|
|
PLA2G7
|
[NCBI]
|
3.56248e-06
|
|
|
HTATIP
|
[NCBI]
|
3.56248e-06
|
|
|
DCTN1
|
[NCBI]
|
3.56248e-06
|
|
|
NOTCH3
|
[NCBI]
|
3.56248e-06
|
|
|
SMARCB1
|
[NCBI]
|
3.56248e-06
|
|
|
FOXE1
|
[NCBI]
|
3.56248e-06
|
|
|
MDC1A
|
[NCBI]
|
3.52554e-06
|
|
|
deafness, conductive, with stapes fixation
|
[NCBI]
|
3.52554e-06
|
|
|
mannosidosis, alpha b, lysosomal
|
[NCBI]
|
3.52554e-06
|
|
|
ehlers-danlos syndrome, type i
|
[NCBI]
|
3.52554e-06
|
|
|
hurler syndrome
|
[NCBI]
|
3.4984e-06
|
|
|
PI
|
[NCBI]
|
3.49771e-06
|
|
|
DAZ
|
[NCBI]
|
3.46885e-06
|
|
|
STAT6
|
[NCBI]
|
3.36338e-06
|
|
|
SLPI
|
[NCBI]
|
3.32455e-06
|
|
|
VLDLR
|
[NCBI]
|
3.3208e-06
|
|
|
GDAP1
|
[NCBI]
|
3.27345e-06
|
|
|
HPSE
|
[NCBI]
|
3.27345e-06
|
|
|
NLK
|
[NCBI]
|
3.27345e-06
|
|
|
DTNBP1
|
[NCBI]
|
3.27345e-06
|
|
|
BMPR2
|
[NCBI]
|
3.27345e-06
|
|
|
EPAS1
|
[NCBI]
|
3.27345e-06
|
|
|
GALE
|
[NCBI]
|
3.27345e-06
|
|
|
PKHD1
|
[NCBI]
|
3.27345e-06
|
|
|
SLC26A3
|
[NCBI]
|
3.27345e-06
|
|
|
NAGLU
|
[NCBI]
|
3.27345e-06
|
|
|
TNFRSF11A
|
[NCBI]
|
3.27345e-06
|
|
|
MHC2TA
|
[NCBI]
|
3.27345e-06
|
|
|
PRDM1
|
[NCBI]
|
3.27345e-06
|
|
|
SGSH
|
[NCBI]
|
3.27345e-06
|
|
|
FOXP2
|
[NCBI]
|
3.27345e-06
|
|
|
HSF1
|
[NCBI]
|
3.27345e-06
|
|
|
NPC1
|
[NCBI]
|
3.23177e-06
|
|
|
CREBBP
|
[NCBI]
|
3.17815e-06
|
|
|
TPT1
|
[NCBI]
|
3.17815e-06
|
|
|
CHNG2
|
[NCBI]
|
3.09707e-06
|
|
|
DRD
|
[NCBI]
|
3.09707e-06
|
|
|
diastrophic dysplasia
|
[NCBI]
|
3.09707e-06
|
|
|
sudden infant death syndrome
|
[NCBI]
|
3.09707e-06
|
|
|
niemann-pick disease, type a
|
[NCBI]
|
3.09707e-06
|
|
|
SLOS
|
[NCBI]
|
3.05347e-06
|
|
|
TLR5
|
[NCBI]
|
3.04066e-06
|
|
|
PANK2
|
[NCBI]
|
3.00927e-06
|
|
|
PRKCA
|
[NCBI]
|
3.00927e-06
|
|
|
CYP1A2
|
[NCBI]
|
3.00927e-06
|
|
|
LEF1
|
[NCBI]
|
3.00927e-06
|
|
|
SNX1
|
[NCBI]
|
3.00927e-06
|
|
|
GJD2
|
[NCBI]
|
3.00927e-06
|
|
|
GABRB3
|
[NCBI]
|
3.00927e-06
|
|
|
UTRN
|
[NCBI]
|
3.00927e-06
|
|
|
NCF1
|
[NCBI]
|
3.00927e-06
|
|
|
PLA2G2A
|
[NCBI]
|
3.00927e-06
|
|
|
EIF2C2
|
[NCBI]
|
3.00927e-06
|
|
|
ATXN3
|
[NCBI]
|
3.00927e-06
|
|
|
CYP2C9
|
[NCBI]
|
3.00927e-06
|
|
|
IKZF1
|
[NCBI]
|
3.00927e-06
|
|
|
ATP1A2
|
[NCBI]
|
3.00927e-06
|
|
|
TLR1
|
[NCBI]
|
3.00927e-06
|
|
|
COL5A1
|
[NCBI]
|
3.00927e-06
|
|
|
RCC1
|
[NCBI]
|
3.00927e-06
|
|
|
POLD1
|
[NCBI]
|
3.00927e-06
|
|
|
KEAP1
|
[NCBI]
|
3.00927e-06
|
|
|
FCGR3A
|
[NCBI]
|
3.00927e-06
|
|
|
LCT
|
[NCBI]
|
2.95967e-06
|
|
|
DCK
|
[NCBI]
|
2.8968e-06
|
|
|
ESD
|
[NCBI]
|
2.88446e-06
|
|
|
ARF1
|
[NCBI]
|
2.78036e-06
|
|
|
LAT
|
[NCBI]
|
2.77203e-06
|
|
|
MEF2A
|
[NCBI]
|
2.76701e-06
|
|
|
DDR1
|
[NCBI]
|
2.76701e-06
|
|
|
MIF
|
[NCBI]
|
2.76701e-06
|
|
|
RNASEL
|
[NCBI]
|
2.76701e-06
|
|
|
PAX1
|
[NCBI]
|
2.76701e-06
|
|
|
MYOD1
|
[NCBI]
|
2.76701e-06
|
|
|
SOX2
|
[NCBI]
|
2.76701e-06
|
|
|
MYO6
|
[NCBI]
|
2.76701e-06
|
|
|
PTTG1
|
[NCBI]
|
2.76701e-06
|
|
|
KLF5
|
[NCBI]
|
2.76701e-06
|
|
|
RAD51
|
[NCBI]
|
2.76701e-06
|
|
|
STX1A
|
[NCBI]
|
2.76701e-06
|
|
|
CYP11A1
|
[NCBI]
|
2.76701e-06
|
|
|
NSD1
|
[NCBI]
|
2.76701e-06
|
|
|
FGB
|
[NCBI]
|
2.76701e-06
|
|
|
PTN
|
[NCBI]
|
2.76189e-06
|
|
|
TLR4
|
[NCBI]
|
2.75144e-06
|
|
|
andersen cardiodysrhythmic periodic paralysis
|
[NCBI]
|
2.70823e-06
|
|
|
glycogen storage disease v
|
[NCBI]
|
2.70823e-06
|
|
|
biotinidase deficiency
|
[NCBI]
|
2.70823e-06
|
|
|
RMD
|
[NCBI]
|
2.70823e-06
|
|
|
EFE
|
[NCBI]
|
2.70823e-06
|
|
|
isoniazid inactivation
|
[NCBI]
|
2.65717e-06
|
|
|
SH2D1A
|
[NCBI]
|
2.65717e-06
|
|
|
hypogonadotropic hypogonadism
|
[NCBI]
|
2.62123e-06
|
|
|
TNFRSF1A
|
[NCBI]
|
2.59331e-06
|
|
|
EXT2
|
[NCBI]
|
2.54422e-06
|
|
|
UCHL1
|
[NCBI]
|
2.54422e-06
|
|
|
SPHK1
|
[NCBI]
|
2.54422e-06
|
|
|
IL6ST
|
[NCBI]
|
2.54422e-06
|
|
|
TGFBR1
|
[NCBI]
|
2.54422e-06
|
|
|
PTS
|
[NCBI]
|
2.54422e-06
|
|
|
CBL
|
[NCBI]
|
2.54422e-06
|
|
|
SURF1
|
[NCBI]
|
2.54422e-06
|
|
|
ALDOA
|
[NCBI]
|
2.54422e-06
|
|
|
GLUD1
|
[NCBI]
|
2.54422e-06
|
|
|
NCOA1
|
[NCBI]
|
2.54422e-06
|
|
|
ACTA1
|
[NCBI]
|
2.54422e-06
|
|
|
RAF1
|
[NCBI]
|
2.54422e-06
|
|
|
Ge
|
[NCBI]
|
2.54422e-06
|
|
|
TCF3
|
[NCBI]
|
2.54422e-06
|
|
|
CYP2D6
|
[NCBI]
|
2.53838e-06
|
|
|
FGFR1
|
[NCBI]
|
2.51996e-06
|
|
|
BBS
|
[NCBI]
|
2.51705e-06
|
|
|
SMN1
|
[NCBI]
|
2.50717e-06
|
|
|
BRCA2
|
[NCBI]
|
2.45089e-06
|
|
|
AGT
|
[NCBI]
|
2.42383e-06
|
|
|
BMP4
|
[NCBI]
|
2.4033e-06
|
|
|
INSR
|
[NCBI]
|
2.38313e-06
|
|
|
INS
|
[NCBI]
|
2.36956e-06
|
|
|
CFNS
|
[NCBI]
|
2.35573e-06
|
|
|
MHA
|
[NCBI]
|
2.35573e-06
|
|
|
FDH
|
[NCBI]
|
2.35573e-06
|
|
|
SEDC
|
[NCBI]
|
2.35573e-06
|
|
|
RNASE2
|
[NCBI]
|
2.34493e-06
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
2.34112e-06
|
|
|
ACTC1
|
[NCBI]
|
2.33885e-06
|
|
|
3-@beta-hydroxysteroid dehydrogenase, type ii, deficiency of
|
[NCBI]
|
2.33885e-06
|
|
|
NR4A2
|
[NCBI]
|
2.33885e-06
|
|
|
LGALS3
|
[NCBI]
|
2.33885e-06
|
|
|
SGCE
|
[NCBI]
|
2.33885e-06
|
|
|
KCNJ2
|
[NCBI]
|
2.33885e-06
|
|
|
CRHR1
|
[NCBI]
|
2.33885e-06
|
|
|
FLT4
|
[NCBI]
|
2.33885e-06
|
|
|
KRIT1
|
[NCBI]
|
2.33885e-06
|
|
|
HMOX1
|
[NCBI]
|
2.33885e-06
|
|
|
RPS6KA1
|
[NCBI]
|
2.33885e-06
|
|
|
MUTYH
|
[NCBI]
|
2.33885e-06
|
|
|
TNFRSF13B
|
[NCBI]
|
2.33885e-06
|
|
|
KCNE1
|
[NCBI]
|
2.33885e-06
|
|
|
PROCR
|
[NCBI]
|
2.31337e-06
|
|
|
ABCC2
|
[NCBI]
|
2.26111e-06
|
|
|
krabbe disease
|
[NCBI]
|
2.25308e-06
|
|
|
TLR2
|
[NCBI]
|
2.24311e-06
|
|
|
tay-sachs disease, ab variant
|
[NCBI]
|
2.14915e-06
|
|
|
CA2
|
[NCBI]
|
2.14915e-06
|
|
|
FTH1
|
[NCBI]
|
2.14915e-06
|
|
|
C9
|
[NCBI]
|
2.14915e-06
|
|
|
SMAD2
|
[NCBI]
|
2.14915e-06
|
|
|
EPB41
|
[NCBI]
|
2.14915e-06
|
|
|
DMBT1
|
[NCBI]
|
2.14915e-06
|
|
|
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase
|
[NCBI]
|
2.14915e-06
|
|
|
CYGB
|
[NCBI]
|
2.14915e-06
|
|
|
EEA1
|
[NCBI]
|
2.14915e-06
|
|
|
SYT1
|
[NCBI]
|
2.14915e-06
|
|
|
HAP1
|
[NCBI]
|
2.14915e-06
|
|
|
AMELX
|
[NCBI]
|
2.14915e-06
|
|
|
SFTPB
|
[NCBI]
|
2.14915e-06
|
|
|
CYP2C19
|
[NCBI]
|
2.14915e-06
|
|
|
NFATC1
|
[NCBI]
|
2.14915e-06
|
|
|
ERCC6
|
[NCBI]
|
2.14915e-06
|
|
|
LPI
|
[NCBI]
|
2.0977e-06
|
|
|
hepatocellular carcinoma
|
[NCBI]
|
2.03666e-06
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
2.03666e-06
|
|
|
pheochromocytoma
|
[NCBI]
|
2.03666e-06
|
|
|
REN
|
[NCBI]
|
2.00504e-06
|
|
|
MAPK1
|
[NCBI]
|
2.00374e-06
|
|
|
TBP
|
[NCBI]
|
2.00295e-06
|
|
|
AT
|
[NCBI]
|
1.98337e-06
|
|
|
CHRNA1
|
[NCBI]
|
1.97364e-06
|
|
|
CLN3
|
[NCBI]
|
1.97364e-06
|
|
|
DCX
|
[NCBI]
|
1.97364e-06
|
|
|
PEX7
|
[NCBI]
|
1.97364e-06
|
|
|
TBX5
|
[NCBI]
|
1.97364e-06
|
|
|
EIF5A
|
[NCBI]
|
1.97364e-06
|
|
|
HR
|
[NCBI]
|
1.97364e-06
|
|
|
CLCN5
|
[NCBI]
|
1.97364e-06
|
|
|
SLC2A1
|
[NCBI]
|
1.97364e-06
|
|
|
SSTR2
|
[NCBI]
|
1.97364e-06
|
|
|
DBA
|
[NCBI]
|
1.94575e-06
|
|
|
CP
|
[NCBI]
|
1.94472e-06
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
1.93295e-06
|
|
|
MEN2A
|
[NCBI]
|
1.93295e-06
|
|
|
SLC2A2
|
[NCBI]
|
1.90951e-06
|
|
|
NRG1
|
[NCBI]
|
1.89362e-06
|
|
|
ERCC1
|
[NCBI]
|
1.81103e-06
|
|
|
HOXD13
|
[NCBI]
|
1.81103e-06
|
|
|
PLSCR1
|
[NCBI]
|
1.81103e-06
|
|
|
MYB
|
[NCBI]
|
1.81103e-06
|
|
|
ATP2A2
|
[NCBI]
|
1.81103e-06
|
|
|
PAX5
|
[NCBI]
|
1.81103e-06
|
|
|
EBF
|
[NCBI]
|
1.81103e-06
|
|
|
GHRHR
|
[NCBI]
|
1.81103e-06
|
|
|
ADAMTS13
|
[NCBI]
|
1.81103e-06
|
|
|
complement component 8 deficiency, type i
|
[NCBI]
|
1.81103e-06
|
|
|
GATA4
|
[NCBI]
|
1.81103e-06
|
|
|
PDGFRB
|
[NCBI]
|
1.81103e-06
|
|
|
gaucher disease, type i
|
[NCBI]
|
1.77332e-06
|
|
|
LMNA
|
[NCBI]
|
1.75371e-06
|
|
|
RCDP1
|
[NCBI]
|
1.74844e-06
|
|
|
OPTB1
|
[NCBI]
|
1.74844e-06
|
|
|
DFNB1
|
[NCBI]
|
1.74844e-06
|
|
|
MS
|
[NCBI]
|
1.74814e-06
|
|
|
RB1
|
[NCBI]
|
1.74045e-06
|
|
|
CDH1
|
[NCBI]
|
1.7286e-06
|
|
|
SLC11A1
|
[NCBI]
|
1.7286e-06
|
|
|
HGPS
|
[NCBI]
|
1.72448e-06
|
|
|
NSF
|
[NCBI]
|
1.6883e-06
|
|
|
TYR
|
[NCBI]
|
1.6883e-06
|
|
|
DLD
|
[NCBI]
|
1.66018e-06
|
|
|
CPD
|
[NCBI]
|
1.66018e-06
|
|
|
RHD
|
[NCBI]
|
1.66018e-06
|
|
|
APTX
|
[NCBI]
|
1.66018e-06
|
|
|
CYP1B1
|
[NCBI]
|
1.66018e-06
|
|
|
LCK
|
[NCBI]
|
1.66018e-06
|
|
|
PKD2
|
[NCBI]
|
1.643e-06
|
|
|
HRAS
|
[NCBI]
|
1.643e-06
|
|
|
HNF4A
|
[NCBI]
|
1.643e-06
|
|
|
SLC18A3
|
[NCBI]
|
1.57151e-06
|
|
|
ITGB3
|
[NCBI]
|
1.56049e-06
|
|
|
UROS
|
[NCBI]
|
1.52012e-06
|
|
|
CDSN
|
[NCBI]
|
1.52012e-06
|
|
|
HNF1B
|
[NCBI]
|
1.52012e-06
|
|
|
CDH23
|
[NCBI]
|
1.52012e-06
|
|
|
CRYAA
|
[NCBI]
|
1.52012e-06
|
|
|
SLC25A20
|
[NCBI]
|
1.52012e-06
|
|
|
EMD
|
[NCBI]
|
1.52012e-06
|
|
|
MFN2
|
[NCBI]
|
1.52012e-06
|
|
|
CASP1
|
[NCBI]
|
1.52012e-06
|
|
|
PPSH
|
[NCBI]
|
1.48878e-06
|
|
|
neural tube defects
|
[NCBI]
|
1.48878e-06
|
|
|
HSAS
|
[NCBI]
|
1.48878e-06
|
|
|
POF1
|
[NCBI]
|
1.48878e-06
|
|
|
prostate cancer
|
[NCBI]
|
1.47017e-06
|
|
|
IL4
|
[NCBI]
|
1.42287e-06
|
|
|
MMP1
|
[NCBI]
|
1.38998e-06
|
|
|
SRD5A2
|
[NCBI]
|
1.38998e-06
|
|
|
GSK3B
|
[NCBI]
|
1.38998e-06
|
|
|
SLC3A1
|
[NCBI]
|
1.38998e-06
|
|
|
AQP5
|
[NCBI]
|
1.38998e-06
|
|
|
CLOCK
|
[NCBI]
|
1.38998e-06
|
|
|
LRP5
|
[NCBI]
|
1.38998e-06
|
|
|
NKX2E
|
[NCBI]
|
1.38998e-06
|
|
|
SLC12A3
|
[NCBI]
|
1.38998e-06
|
|
|
BIRC1
|
[NCBI]
|
1.33061e-06
|
|
|
EIF4E
|
[NCBI]
|
1.33061e-06
|
|
|
SRC
|
[NCBI]
|
1.32978e-06
|
|
|
TCOF
|
[NCBI]
|
1.327e-06
|
|
|
LDHB
|
[NCBI]
|
1.26901e-06
|
|
|
PMS2
|
[NCBI]
|
1.26901e-06
|
|
|
NRAS
|
[NCBI]
|
1.26901e-06
|
|
|
pta deficiency
|
[NCBI]
|
1.26901e-06
|
|
|
ETS1
|
[NCBI]
|
1.26901e-06
|
|
|
CDKN1C
|
[NCBI]
|
1.26901e-06
|
|
|
NOTCH1
|
[NCBI]
|
1.25956e-06
|
|
|
CD36
|
[NCBI]
|
1.25956e-06
|
|
|
ATRX
|
[NCBI]
|
1.25565e-06
|
|
|
testicular tumors
|
[NCBI]
|
1.25565e-06
|
|
|
pyruvate decarboxylase deficiency
|
[NCBI]
|
1.25565e-06
|
|
|
STAT3
|
[NCBI]
|
1.25269e-06
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
1.24811e-06
|
|
|
HDAC1
|
[NCBI]
|
1.22249e-06
|
|
|
PXE
|
[NCBI]
|
1.19784e-06
|
|
|
PCI
|
[NCBI]
|
1.17102e-06
|
|
|
PLG
|
[NCBI]
|
1.16443e-06
|
|
|
IL4R
|
[NCBI]
|
1.15651e-06
|
|
|
AHSG
|
[NCBI]
|
1.15651e-06
|
|
|
CRYAB
|
[NCBI]
|
1.15651e-06
|
|
|
CREB1
|
[NCBI]
|
1.15651e-06
|
|
|
ATXN8OS
|
[NCBI]
|
1.15651e-06
|
|
|
NR5A1
|
[NCBI]
|
1.12534e-06
|
|
|
CTNNB1
|
[NCBI]
|
1.12534e-06
|
|
|
MAOA
|
[NCBI]
|
1.12095e-06
|
|
|
TERT
|
[NCBI]
|
1.10457e-06
|
|
|
CMH
|
[NCBI]
|
1.07112e-06
|
|
|
THPO
|
[NCBI]
|
1.06202e-06
|
|
|
IVD
|
[NCBI]
|
1.05189e-06
|
|
|
CES1
|
[NCBI]
|
1.05189e-06
|
|
|
PTCH1
|
[NCBI]
|
1.05189e-06
|
|
|
TNFRSF6B
|
[NCBI]
|
1.05189e-06
|
|
|
IFNGR1
|
[NCBI]
|
1.05189e-06
|
|
|
hypophosphatasia, infantile
|
[NCBI]
|
1.04721e-06
|
|
|
DKC
|
[NCBI]
|
1.04721e-06
|
|
|
STL1
|
[NCBI]
|
1.04721e-06
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
1.00326e-06
|
|
|
PABPC1
|
[NCBI]
|
9.982e-07
|
|
|
APOB
|
[NCBI]
|
9.93248e-07
|
|
|
menkes disease
|
[NCBI]
|
9.80043e-07
|
|
|
IPF1
|
[NCBI]
|
9.54608e-07
|
|
|
DLG1
|
[NCBI]
|
9.54608e-07
|
|
|
NOG
|
[NCBI]
|
9.54608e-07
|
|
|
TAF1
|
[NCBI]
|
9.54608e-07
|
|
|
CD2AP
|
[NCBI]
|
9.54608e-07
|
|
|
ARX
|
[NCBI]
|
9.54608e-07
|
|
|
IGF2R
|
[NCBI]
|
9.54608e-07
|
|
|
PLK1
|
[NCBI]
|
9.37977e-07
|
|
|
DRPLA
|
[NCBI]
|
9.13052e-07
|
|
|
HLA-A
|
[NCBI]
|
9.10973e-07
|
|
|
PPARG
|
[NCBI]
|
8.90945e-07
|
|
|
CHUK
|
[NCBI]
|
8.64164e-07
|
|
|
TTN
|
[NCBI]
|
8.64164e-07
|
|
|
DISC1
|
[NCBI]
|
8.64164e-07
|
|
|
GP1BA
|
[NCBI]
|
8.64164e-07
|
|
|
XPC
|
[NCBI]
|
8.64164e-07
|
|
|
PLD2
|
[NCBI]
|
8.64164e-07
|
|
|
NCOA2
|
[NCBI]
|
8.64164e-07
|
|
|
PTX3
|
[NCBI]
|
8.64164e-07
|
|
|
NOS2A
|
[NCBI]
|
8.64164e-07
|
|
|
TP73L
|
[NCBI]
|
8.64164e-07
|
|
|
exostoses, multiple, type i
|
[NCBI]
|
8.61827e-07
|
|
|
FPLD2
|
[NCBI]
|
8.61827e-07
|
|
|
hypertension, essential
|
[NCBI]
|
8.59965e-07
|
|
|
NR0B2
|
[NCBI]
|
8.32363e-07
|
|
|
UCP3
|
[NCBI]
|
8.26591e-07
|
|
|
SLS
|
[NCBI]
|
8.15059e-07
|
|
|
PD
|
[NCBI]
|
7.8629e-07
|
|
|
NMB
|
[NCBI]
|
7.85507e-07
|
|
|
complement component 6 deficiency
|
[NCBI]
|
7.80121e-07
|
|
|
APOH
|
[NCBI]
|
7.80121e-07
|
|
|
CYP11B2
|
[NCBI]
|
7.80121e-07
|
|
|
TWIST1
|
[NCBI]
|
7.80121e-07
|
|
|
PPIA
|
[NCBI]
|
7.68385e-07
|
|
|
HPRT1
|
[NCBI]
|
7.68385e-07
|
|
|
ZFP36
|
[NCBI]
|
7.45183e-07
|
|
|
ASS
|
[NCBI]
|
7.05636e-07
|
|
|
AK1
|
[NCBI]
|
7.02079e-07
|
|
|
GLI3
|
[NCBI]
|
7.02079e-07
|
|
|
CRY1
|
[NCBI]
|
7.02079e-07
|
|
|
neuraminidase deficiency with beta-galactosidase deficiency
|
[NCBI]
|
7.02079e-07
|
|
|
SLC40A1
|
[NCBI]
|
7.02079e-07
|
|
|
fructose intolerance, hereditary
|
[NCBI]
|
7.02079e-07
|
|
|
MEFV
|
[NCBI]
|
7.02079e-07
|
|
|
DCN
|
[NCBI]
|
7.02079e-07
|
|
|
CETP
|
[NCBI]
|
7.02079e-07
|
|
|
gastric cancer
|
[NCBI]
|
6.98001e-07
|
|
|
ABCB1
|
[NCBI]
|
6.8481e-07
|
|
|
STAT5A
|
[NCBI]
|
6.8481e-07
|
|
|
MYC
|
[NCBI]
|
6.66886e-07
|
|
|
MARCKS
|
[NCBI]
|
6.29674e-07
|
|
|
IL8
|
[NCBI]
|
6.29674e-07
|
|
|
oca2 gene
|
[NCBI]
|
6.29674e-07
|
|
|
RAC1
|
[NCBI]
|
6.29674e-07
|
|
|
MN
|
[NCBI]
|
6.29674e-07
|
|
|
ADA
|
[NCBI]
|
6.26735e-07
|
|
|
GHR
|
[NCBI]
|
6.04554e-07
|
|
|
RCC1
|
[NCBI]
|
5.98691e-07
|
|
|
BSG
|
[NCBI]
|
5.91847e-07
|
|
|
CCND1
|
[NCBI]
|
5.88062e-07
|
|
|
OPMD
|
[NCBI]
|
5.83453e-07
|
|
|
UGCG
|
[NCBI]
|
5.62575e-07
|
|
|
CDKN1A
|
[NCBI]
|
5.62575e-07
|
|
|
PAFAH1B1
|
[NCBI]
|
5.62575e-07
|
|
|
CVS
|
[NCBI]
|
5.54389e-07
|
|
|
alopecia, androgenetic
|
[NCBI]
|
5.52314e-07
|
|
|
SLC11A2
|
[NCBI]
|
5.52077e-07
|
|
|
SMS
|
[NCBI]
|
5.46781e-07
|
|
|
MITF
|
[NCBI]
|
5.23872e-07
|
|
|
UCP1
|
[NCBI]
|
5.16418e-07
|
|
|
ARPKD
|
[NCBI]
|
5.01289e-07
|
|
|
ERCC5
|
[NCBI]
|
5.00477e-07
|
|
|
PEPD
|
[NCBI]
|
5.00477e-07
|
|
|
NBS1
|
[NCBI]
|
5.00477e-07
|
|
|
CDK6
|
[NCBI]
|
5.00477e-07
|
|
|
complement component 2 deficiency
|
[NCBI]
|
5.00477e-07
|
|
|
PRKDC
|
[NCBI]
|
5.00477e-07
|
|
|
QTRT1
|
[NCBI]
|
5.00477e-07
|
|
|
ALK
|
[NCBI]
|
4.74587e-07
|
|
|
LRP1
|
[NCBI]
|
4.51963e-07
|
|
|
CXCR4
|
[NCBI]
|
4.43104e-07
|
|
|
FHIT
|
[NCBI]
|
4.43104e-07
|
|
|
SLAMF1
|
[NCBI]
|
4.43104e-07
|
|
|
STAT5B
|
[NCBI]
|
4.43104e-07
|
|
|
GHRL
|
[NCBI]
|
4.43104e-07
|
|
|
myoclonic dystonia
|
[NCBI]
|
4.29764e-07
|
|
|
SPG4
|
[NCBI]
|
4.29764e-07
|
|
|
PARP1
|
[NCBI]
|
4.19569e-07
|
|
|
WS1
|
[NCBI]
|
4.11449e-07
|
|
|
SCA7
|
[NCBI]
|
4.11449e-07
|
|
|
NR6A1
|
[NCBI]
|
3.90199e-07
|
|
|
RPS6KA3
|
[NCBI]
|
3.90199e-07
|
|
|
GATA1
|
[NCBI]
|
3.90199e-07
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
3.88562e-07
|
|
|
GK
|
[NCBI]
|
3.41527e-07
|
|
|
MHS1
|
[NCBI]
|
3.29474e-07
|
|
|
OCA2
|
[NCBI]
|
3.23011e-07
|
|
|
drug metabolism, poor, cyp2d6-related
|
[NCBI]
|
3.23011e-07
|
|
|
sandhoff disease
|
[NCBI]
|
3.23011e-07
|
|
|
TBS
|
[NCBI]
|
3.23011e-07
|
|
|
PLN
|
[NCBI]
|
3.09279e-07
|
|
|
VCP
|
[NCBI]
|
2.99015e-07
|
|
|
GRIA2
|
[NCBI]
|
2.96872e-07
|
|
|
MICA
|
[NCBI]
|
2.96872e-07
|
|
|
JAG1
|
[NCBI]
|
2.96872e-07
|
|
|
ADRB2
|
[NCBI]
|
2.96872e-07
|
|
|
ABO
|
[NCBI]
|
2.96872e-07
|
|
|
OPTN
|
[NCBI]
|
2.96872e-07
|
|
|
MC4R
|
[NCBI]
|
2.71489e-07
|
|
|
DRD4
|
[NCBI]
|
2.71489e-07
|
|
|
HNMT
|
[NCBI]
|
2.56032e-07
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
2.56032e-07
|
|
|
NOD2
|
[NCBI]
|
2.56032e-07
|
|
|
SMA1
|
[NCBI]
|
2.55773e-07
|
|
|
AHO
|
[NCBI]
|
2.55773e-07
|
|
|
obesity
|
[NCBI]
|
2.55686e-07
|
|
|
OPA1
|
[NCBI]
|
2.33107e-07
|
|
|
GCPS
|
[NCBI]
|
2.33107e-07
|
|
|
CLN3
|
[NCBI]
|
2.33107e-07
|
|
|
malaria, susceptibility to
|
[NCBI]
|
2.33107e-07
|
|
|
MAPK3
|
[NCBI]
|
2.19773e-07
|
|
|
PAX3
|
[NCBI]
|
2.19773e-07
|
|
|
TNFRSF1B
|
[NCBI]
|
2.18822e-07
|
|
|
FY
|
[NCBI]
|
2.18822e-07
|
|
|
SNRPN
|
[NCBI]
|
2.18822e-07
|
|
|
glioma of brain, familial
|
[NCBI]
|
1.90424e-07
|
|
|
LNS
|
[NCBI]
|
1.90424e-07
|
|
|
BRRS
|
[NCBI]
|
1.90424e-07
|
|
|
MST1
|
[NCBI]
|
1.85067e-07
|
|
|
H19
|
[NCBI]
|
1.85067e-07
|
|
|
FXYD1
|
[NCBI]
|
1.85067e-07
|
|
|
SLC16A1
|
[NCBI]
|
1.85067e-07
|
|
|
ichthyosis, x-linked
|
[NCBI]
|
1.83881e-07
|
|
|
COH1
|
[NCBI]
|
1.59116e-07
|
|
|
lactase persistence
|
[NCBI]
|
1.59116e-07
|
|
|
CTLA4
|
[NCBI]
|
1.54609e-07
|
|
|
SEMA3A
|
[NCBI]
|
1.54609e-07
|
|
|
ARF6
|
[NCBI]
|
1.54609e-07
|
|
|
NS1
|
[NCBI]
|
1.52296e-07
|
|
|
CDC2
|
[NCBI]
|
1.51018e-07
|
|
|
AMACR
|
[NCBI]
|
1.27296e-07
|
|
|
SPINK1
|
[NCBI]
|
1.10855e-07
|
|
|
SOX9
|
[NCBI]
|
1.02989e-07
|
|
|
PDS
|
[NCBI]
|
1.00179e-07
|
|
|
DNTT
|
[NCBI]
|
9.36897e-08
|
|
|
SCA6
|
[NCBI]
|
8.69539e-08
|
|
|
REST
|
[NCBI]
|
8.15577e-08
|
|
|
C4A
|
[NCBI]
|
8.15577e-08
|
|
|
TCRA
|
[NCBI]
|
8.15577e-08
|
|
|
ZNF145
|
[NCBI]
|
8.15577e-08
|
|
|
SPTA1
|
[NCBI]
|
7.73006e-08
|
|
|
CGD
|
[NCBI]
|
7.66093e-08
|
|
|
APS1
|
[NCBI]
|
6.92605e-08
|
|
|
CFH
|
[NCBI]
|
6.30343e-08
|
|
|
DNMT1
|
[NCBI]
|
5.33014e-08
|
|
|
sotos syndrome
|
[NCBI]
|
4.95446e-08
|
|
|
AQP4
|
[NCBI]
|
4.886e-08
|
|
|
KLF1
|
[NCBI]
|
4.886e-08
|
|
|
WRN
|
[NCBI]
|
4.87438e-08
|
|
|
DCT
|
[NCBI]
|
4.68386e-08
|
|
|
TSC1
|
[NCBI]
|
4.68386e-08
|
|
|
AIRE
|
[NCBI]
|
4.45053e-08
|
|
|
ESR1
|
[NCBI]
|
4.38729e-08
|
|
|
PRKCM
|
[NCBI]
|
4.38729e-08
|
|
|
GJA1
|
[NCBI]
|
4.16044e-08
|
|
|
VASP
|
[NCBI]
|
4.05212e-08
|
|
|
PAM
|
[NCBI]
|
3.55257e-08
|
|
|
SRF
|
[NCBI]
|
3.43598e-08
|
|
|
ENPP2
|
[NCBI]
|
3.33286e-08
|
|
|
ALAD
|
[NCBI]
|
3.33286e-08
|
|
|
ADAM17
|
[NCBI]
|
3.33286e-08
|
|
|
FGF2
|
[NCBI]
|
3.32804e-08
|
|
|
HPS
|
[NCBI]
|
2.98354e-08
|
|
|
hypophosphatemic rickets, x-linked dominant
|
[NCBI]
|
2.43582e-08
|
|
|
SMEI
|
[NCBI]
|
2.43582e-08
|
|
|
spermatogenic failure, nonobstructive, y-linked
|
[NCBI]
|
2.22631e-08
|
|
|
LAD
|
[NCBI]
|
2.22631e-08
|
|
|
HCRT
|
[NCBI]
|
2.22479e-08
|
|
|
MSTN
|
[NCBI]
|
2.22479e-08
|
|
|
FGF23
|
[NCBI]
|
2.22479e-08
|
|
|
IDE
|
[NCBI]
|
1.9954e-08
|
|
|
IGF2
|
[NCBI]
|
1.77585e-08
|
|
|
RP2
|
[NCBI]
|
1.35011e-08
|
|
|
NAT1
|
[NCBI]
|
1.06814e-08
|
|
|
HS
|
[NCBI]
|
6.99866e-09
|
|
|
pyruvate kinase deficiency of red cells
|
[NCBI]
|
6.06618e-09
|
|
|
IGER
|
[NCBI]
|
6.06618e-09
|
|
|
XPA
|
[NCBI]
|
5.58043e-09
|
|
|
PGM1
|
[NCBI]
|
5.34352e-09
|
|
|
RIPK1
|
[NCBI]
|
2.65573e-09
|
|
|
CPB2
|
[NCBI]
|
2.53843e-09
|
|
|
SLC18A2
|
[NCBI]
|
1.80595e-09
|
|
|
INSL3
|
[NCBI]
|
1.80595e-09
|
|
|
PC
|
[NCBI]
|
1.4648e-09
|
|
|
TS
|
[NCBI]
|
7.45875e-10
|
|
|
ILK
|
[NCBI]
|
5.32227e-10
|
|
|
RLBP1
|
[NCBI]
|
3.9237e-10
|
|
|
ITGB2
|
[NCBI]
|
1.32965e-10
|
|
|
adrenoleukodystrophy, autosomal neonatal form
|
[NCBI]
|
9.58434e-13
|
|